{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T17:20:46Z","timestamp":1793726446895,"version":"4.6.1"},"reference-count":401,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.neuropharm.2024.110217","type":"journal-article","created":{"date-parts":[[2024,11,16]],"date-time":"2024-11-16T16:08:18Z","timestamp":1731773298000},"page":"110217","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":45,"special_numbering":"C","title":["Mitochondrial DAMPs: Key mediators in neuroinflammation and neurodegenerative disease pathogenesis"],"prefix":"10.1016","volume":"264","author":[{"given":"Haihan","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaidi","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yage","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziheng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziqing","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.neuropharm.2024.110217_bib1","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/0163-7258(94)00048-4","article-title":"Purinoceptors: are there families of P2X and P2Y purinoceptors?","volume":"64","author":"Abbracchio","year":"1994","journal-title":"Pharmacol. Ther."},{"issue":"3","key":"10.1016\/j.neuropharm.2024.110217_bib2","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1124\/pr.58.3.3","article-title":"International Union of Pharmacology LVIII: update on the P2Y G protein-coupled nucleotide receptors: from molecular mechanisms and pathophysiology to therapy","volume":"58","author":"Abbracchio","year":"2006","journal-title":"Pharmacol. Rev."},{"issue":"5","key":"10.1016\/j.neuropharm.2024.110217_bib3","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1111\/jnc.13087","article-title":"Neuroprotective effects of vildagliptin in rat rotenone Parkinson's disease model: role of RAGE-NF\u03baB and Nrf2-antioxidant signaling pathways","volume":"133","author":"Abdelsalam","year":"2015","journal-title":"J. Neurochem."},{"issue":"3","key":"10.1016\/j.neuropharm.2024.110217_bib4","doi-asserted-by":"crossref","first-page":"C343","DOI":"10.1152\/ajpcell.00095.2018","article-title":"Blood-brain barrier dysfunction in ischemic stroke: targeting tight junctions and transporters for vascular protection","volume":"315","author":"Abdullahi","year":"2018","journal-title":"Am. J. Physiol. Cell Physiol."},{"issue":"10","key":"10.1016\/j.neuropharm.2024.110217_bib5","doi-asserted-by":"crossref","first-page":"5328","DOI":"10.1128\/JVI.00037-14","article-title":"Cytosolic-DNA-mediated, STING-dependent proinflammatory gene induction necessitates canonical NF-\u03baB activation through TBK1","volume":"88","author":"Abe","year":"2014","journal-title":"J. Virol."},{"issue":"5","key":"10.1016\/j.neuropharm.2024.110217_bib6","doi-asserted-by":"crossref","DOI":"10.3390\/antiox12051075","article-title":"PGC-1\u03b1 is a master regulator of mitochondrial lifecycle and ROS stress response","volume":"12","author":"Abu Shelbayeh","year":"2023","journal-title":"Antioxidants"},{"issue":"5","key":"10.1016\/j.neuropharm.2024.110217_bib7","doi-asserted-by":"crossref","DOI":"10.1002\/jbt.23022","article-title":"Dihydroquercetin improves rotenone-induced Parkinsonism by regulating NF-\u03baB-mediated inflammation pathway in rats","volume":"36","author":"Akinmoladun","year":"2022","journal-title":"J. Biochem. Mol. Toxicol."},{"issue":"8","key":"10.1016\/j.neuropharm.2024.110217_bib8","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1038\/90609","article-title":"Toll-like receptors: critical proteins linking innate and acquired immunity","volume":"2","author":"Akira","year":"2001","journal-title":"Nat. Immunol."},{"issue":"4","key":"10.1016\/j.neuropharm.2024.110217_bib9","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.cell.2006.02.015","article-title":"Pathogen recognition and innate immunity","volume":"124","author":"Akira","year":"2006","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.neuropharm.2024.110217_bib10","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1007\/s12017-019-08588-w","article-title":"Mitochondrial DNA copy number in peripheral blood as a potential non-invasive biomarker for multiple sclerosis","volume":"22","author":"Al-Kafaji","year":"2020","journal-title":"NeuroMolecular Med."},{"issue":"6","key":"10.1016\/j.neuropharm.2024.110217_bib11","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1093\/nar\/gkg251","article-title":"Human mitochondrial DNA is packaged with TFAM","volume":"31","author":"Alam","year":"2003","journal-title":"Nucleic Acids Res."},{"issue":"9","key":"10.1016\/j.neuropharm.2024.110217_bib12","doi-asserted-by":"crossref","first-page":"4089","DOI":"10.4049\/jimmunol.1402793","article-title":"Cutting edge: antimalarial drugs inhibit IFN-\u03b2 production through blockade of cyclic GMP-AMP synthase-DNA interaction","volume":"194","author":"An","year":"2015","journal-title":"J. Immunol."},{"issue":"11","key":"10.1016\/j.neuropharm.2024.110217_bib13","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1002\/art.40559","article-title":"Inhibition of cyclic GMP-AMP synthase using a novel antimalarial drug derivative in trex1-deficient mice","volume":"70","author":"An","year":"2018","journal-title":"Arthritis Rheumatol."},{"issue":"1","key":"10.1016\/j.neuropharm.2024.110217_bib14","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1083\/jcb.200207030","article-title":"Mitochondrial targeting and a novel transmembrane arrest of Alzheimer's amyloid precursor protein impairs mitochondrial function in neuronal cells","volume":"161","author":"Anandatheerthavarada","year":"2003","journal-title":"J. Cell Biol."},{"issue":"23","key":"10.1016\/j.neuropharm.2024.110217_bib15","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232315182","article-title":"The relationship between reactive oxygen species and the cGAS\/STING signaling pathway in the inflammaging process","volume":"23","author":"Andrade","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuropharm.2024.110217_bib16","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.expneurol.2019.04.007","article-title":"Detection of brain specific cardiolipins in plasma after experimental pediatric head injury","volume":"316","author":"Anthonymuthu","year":"2019","journal-title":"Exp. Neurol."},{"issue":"1","key":"10.1016\/j.neuropharm.2024.110217_bib17","first-page":"4","article-title":"The microglial-motoneuron dialogue in ALS","volume":"30","author":"Appel","year":"2011","journal-title":"Acta Myol."},{"key":"10.1016\/j.neuropharm.2024.110217_bib18","doi-asserted-by":"crossref","first-page":"191","DOI":"10.3389\/fnmol.2017.00191","article-title":"The pathophysiological role of microglia in dynamic surveillance, phagocytosis and structural remodeling of the developing CNS","volume":"10","author":"Arcuri","year":"2017","journal-title":"Front. Mol. Neurosci."},{"issue":"6","key":"10.1016\/j.neuropharm.2024.110217_bib19","doi-asserted-by":"crossref","first-page":"545","DOI":"10.2174\/1566524023362159","article-title":"Toll-like receptor 9, CpG DNA and innate immunity","volume":"2","author":"Ashkar","year":"2002","journal-title":"Curr. Mol. Med."},{"key":"10.1016\/j.neuropharm.2024.110217_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.nicl.2021.102672","article-title":"Ibudilast (MN-166) in amyotrophic lateral sclerosis- an open label, safety and pharmacodynamic trial","volume":"30","author":"Babu","year":"2021","journal-title":"Neuroimage Clin"},{"issue":"2","key":"10.1016\/j.neuropharm.2024.110217_bib21","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.neuro.2010.01.001","article-title":"Differential expression of TRPM2 and TRPV4 channels and their potential role in oxidative stress-induced cell death in organotypic hippocampal culture","volume":"31","author":"Bai","year":"2010","journal-title":"Neurotoxicology"},{"issue":"5","key":"10.1016\/j.neuropharm.2024.110217_bib22","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1021\/acs.jmedchem.5b01091","article-title":"Inhibiting the inflammasome: a chemical perspective","volume":"59","author":"Baldwin","year":"2016","journal-title":"J. Med. Chem."},{"issue":"6","key":"10.1016\/j.neuropharm.2024.110217_bib23","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1023\/B:BIRY.0000033731.50496.01","article-title":"Human deoxyribonucleases","volume":"69","author":"Baranovskii","year":"2004","journal-title":"Biochemistry (Mosc.)"},{"issue":"5","key":"10.1016\/j.neuropharm.2024.110217_bib24","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21051772","article-title":"PINK1\/Parkin mediated mitophagy, Ca(2+) signalling, and ER-mitochondria contacts in Parkinson's disease","volume":"21","author":"Barazzuol","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.neuropharm.2024.110217_bib25","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.neuron.2008.10.013","article-title":"The mystery and magic of glia: a perspective on their roles in health and disease","volume":"60","author":"Barres","year":"2008","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2024.110217_bib26","article-title":"Huntington disease","volume":"1","author":"Bates","year":"2015","journal-title":"Nat. Rev. Dis. Prim."},{"issue":"2","key":"10.1016\/j.neuropharm.2024.110217_bib27","doi-asserted-by":"crossref","first-page":"787","DOI":"10.4049\/jimmunol.0901363","article-title":"Cutting edge: NF-kappaB activating pattern recognition and cytokine receptors license NLRP3 inflammasome activation by regulating NLRP3 expression","volume":"183","author":"Bauernfeind","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.neuropharm.2024.110217_bib28","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/9914854","article-title":"Toll-like receptors: general molecular and structural biology","volume":"2021","author":"Behzadi","year":"2021","journal-title":"J Immunol Res"},{"issue":"5","key":"10.1016\/j.neuropharm.2024.110217_bib29","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1038\/aps.2018.31","article-title":"TRPM2: a candidate therapeutic target for treating neurological diseases","volume":"39","author":"Belrose","year":"2018","journal-title":"Acta Pharmacol. Sin."},{"issue":"23","key":"10.1016\/j.neuropharm.2024.110217_bib30","doi-asserted-by":"crossref","DOI":"10.3390\/cells11233866","article-title":"Mitochondrial permeability transition","volume":"11","author":"Bernardi","year":"2022","journal-title":"Cells"},{"issue":"3","key":"10.1016\/j.neuropharm.2024.110217_bib31","doi-asserted-by":"crossref","DOI":"10.3390\/ma15030804","article-title":"Applications of phyto-nanotechnology for the treatment of neurodegenerative disorders","volume":"15","author":"Bhattacharya","year":"2022","journal-title":"Materials"},{"issue":"2","key":"10.1016\/j.neuropharm.2024.110217_bib32","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1007\/s12031-017-0924-y","article-title":"Formyl peptide receptor 1-mediated glial cell activation in a mouse model of cuprizone-induced demyelination","volume":"62","author":"Bihler","year":"2017","journal-title":"J. Mol. Neurosci."},{"issue":"8","key":"10.1016\/j.neuropharm.2024.110217_bib33","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1084\/jem.20080178","article-title":"A novel pathogenic pathway of immune activation detectable before clinical onset in Huntington's disease","volume":"205","author":"Bj\u00f6rkqvist","year":"2008","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.neuropharm.2024.110217_bib34","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.coph.2018.05.012","article-title":"Exploiting vita-PAMPs in vaccines","volume":"41","author":"Blander","year":"2018","journal-title":"Curr. Opin. Pharmacol."},{"issue":"7","key":"10.1016\/j.neuropharm.2024.110217_bib35","doi-asserted-by":"crossref","first-page":"3812","DOI":"10.4049\/jimmunol.170.7.3812","article-title":"A role for triggering receptor expressed on myeloid cells-1 in host defense during the early-induced and adaptive phases of the immune response","volume":"170","author":"Bleharski","year":"2003","journal-title":"J. Immunol."},{"key":"10.1016\/j.neuropharm.2024.110217_bib36","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2022.879021","article-title":"The NLRP3 inflammasome pathway: a review of mechanisms and inhibitors for the treatment of inflammatory diseases","volume":"14","author":"Blevins","year":"2022","journal-title":"Front. Aging Neurosci."},{"issue":"1","key":"10.1016\/j.neuropharm.2024.110217_bib37","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nrn2038","article-title":"Microglia-mediated neurotoxicity: uncovering the molecular mechanisms","volume":"8","author":"Block","year":"2007","journal-title":"Nat. Rev. Neurosci."},{"issue":"1","key":"10.1016\/j.neuropharm.2024.110217_bib38","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-15807-6","article-title":"Therapeutic targeting of extracellular DNA improves the outcome of intestinal ischemic reperfusion injury in neonatal rats","volume":"7","author":"Boettcher","year":"2017","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.neuropharm.2024.110217_bib39","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1038\/nprot.2016.064","article-title":"Comprehensive analysis of mitochondrial permeability transition pore activity in living cells using fluorescence-imaging-based techniques","volume":"11","author":"Bonora","year":"2016","journal-title":"Nat. Protoc."},{"issue":"5","key":"10.1016\/j.neuropharm.2024.110217_bib40","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.cell.2007.05.018","article-title":"GEFs and GAPs: critical elements in the control of small G proteins","volume":"129","author":"Bos","year":"2007","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.neuropharm.2024.110217_bib41","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/0006-291X(90)91143-G","article-title":"Synthesis and use of a novel N-formyl peptide derivative to isolate a human N-formyl peptide receptor cDNA","volume":"168","author":"Boulay","year":"1990","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"7","key":"10.1016\/j.neuropharm.2024.110217_bib42","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/nri.2016.58","article-title":"Inflammasomes: mechanism of assembly, regulation and signalling","volume":"16","author":"Broz","year":"2016","journal-title":"Nat. Rev. Immunol."},{"issue":"9","key":"10.1016\/j.neuropharm.2024.110217_bib43","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.tcb.2009.06.002","article-title":"Molecular mechanisms involved in inflammasome activation","volume":"19","author":"Bryant","year":"2009","journal-title":"Trends Cell Biol."},{"issue":"7","key":"10.1016\/j.neuropharm.2024.110217_bib44","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/nrd2605","article-title":"Purinergic signalling and disorders of the central nervous system","volume":"7","author":"Burnstock","year":"2008","journal-title":"Nat. Rev. Drug Discov."},{"issue":"1","key":"10.1016\/j.neuropharm.2024.110217_bib45","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1515\/hsz-2021-0258","article-title":"Emerging contributions of formyl peptide receptors to neurodegenerative diseases","volume":"403","author":"Busch","year":"2022","journal-title":"Biol. Chem."},{"issue":"3","key":"10.1016\/j.neuropharm.2024.110217_bib46","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/s41583-019-0132-6","article-title":"Oxidative stress, dysfunctional glucose metabolism and Alzheimer disease","volume":"20","author":"Butterfield","year":"2019","journal-title":"Nat. Rev. Neurosci."},{"issue":"5","key":"10.1016\/j.neuropharm.2024.110217_bib47","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1084\/jem.20151876","article-title":"Oxidized mitochondrial nucleoids released by neutrophils drive type I interferon production in human lupus","volume":"213","author":"Caielli","year":"2016","journal-title":"J. Exp. Med."},{"issue":"2","key":"10.1016\/j.neuropharm.2024.110217_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbamem.2019.183064","article-title":"Tau-induced mitochondrial membrane perturbation is dependent upon cardiolipin","volume":"1862","author":"Camilleri","year":"2020","journal-title":"Biochim. Biophys. Acta Biomembr."},{"issue":"9\u201310","key":"10.1016\/j.neuropharm.2024.110217_bib49","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/j.bbagrm.2012.03.002","article-title":"Mitochondrial transcription factor A regulates mitochondrial transcription initiation, DNA packaging, and genome copy number","volume":"1819","author":"Campbell","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"issue":"1","key":"10.1016\/j.neuropharm.2024.110217_bib50","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/nri.2015.8","article-title":"Self-regulation and cross-regulation of pattern-recognition receptor signalling in health and disease","volume":"16","author":"Cao","year":"2016","journal-title":"Nat. Rev. Immunol."},{"issue":"8","key":"10.1016\/j.neuropharm.2024.110217_bib51","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1038\/nchembio.610","article-title":"AMP-activated protein kinase: nature's energy sensor","volume":"7","author":"Carling","year":"2011","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.neuropharm.2024.110217_bib52","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.neuroscience.2011.02.001","article-title":"Toll-like receptor signaling in amyotrophic lateral sclerosis spinal cord tissue Absence of toll-like receptor 4 (TLR4) extends survival in the hSOD1 G93A mouse model of amyotrophic lateral sclerosis","volume":"179","author":"Casula","year":"2011","journal-title":"Neuroscience"},{"issue":"4","key":"10.1016\/j.neuropharm.2024.110217_bib53","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1007\/s13311-016-0477-8","article-title":"Astrocytes: integrative regulators of neuroinflammation in stroke and other neurological diseases","volume":"13","author":"Cekanaviciute","year":"2016","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.neuropharm.2024.110217_bib54","doi-asserted-by":"crossref","first-page":"192.e191","DOI":"10.1016\/j.neurobiolaging.2016.12.009","article-title":"Cerebrospinal fluid mitochondrial DNA in the Alzheimer's disease continuum","volume":"53","author":"Cervera-Carles","year":"2017","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neuropharm.2024.110217_bib55","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1146\/annurev-pathmechdis-012419-032711","article-title":"Mitochondrial dynamics and its involvement in disease","volume":"15","author":"Chan","year":"2020","journal-title":"Annu. Rev. Pathol."},{"issue":"16","key":"10.1016\/j.neuropharm.2024.110217_bib56","doi-asserted-by":"crossref","first-page":"3048","DOI":"10.1093\/hmg\/ddp243","article-title":"Impaired PGC-1alpha function in muscle in Huntington's disease","volume":"18","author":"Chaturvedi","year":"2009","journal-title":"Hum. Mol. Genet."},{"issue":"12","key":"10.1016\/j.neuropharm.2024.110217_bib57","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1038\/nri2873","article-title":"Sterile inflammation: sensing and reacting to damage","volume":"10","author":"Chen","year":"2010","journal-title":"Nat. Rev. Immunol."},{"issue":"2","key":"10.1016\/j.neuropharm.2024.110217_bib58","doi-asserted-by":"crossref","first-page":"177","DOI":"10.3233\/JAD-2007-12208","article-title":"Amyloid-beta-induced mitochondrial dysfunction","volume":"12","author":"Chen","year":"2007","journal-title":"J Alzheimers Dis"},{"issue":"3","key":"10.1016\/j.neuropharm.2024.110217_bib59","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.4049\/jimmunol.178.3.1759","article-title":"Induction of the formyl peptide receptor 2 in microglia by IFN-gamma and synergy with CD40 ligand","volume":"178","author":"Chen","year":"2007","journal-title":"J. Immunol."},{"issue":"10","key":"10.1016\/j.neuropharm.2024.110217_bib60","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1038\/ni.3558","article-title":"Regulation and function of the cGAS-STING pathway of cytosolic DNA sensing","volume":"17","author":"Chen","year":"2016","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.neuropharm.2024.110217_bib61","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jaut.2017.06.012","article-title":"Regulation of inflammation by members of the formyl-peptide receptor family","volume":"85","author":"Chen","year":"2017","journal-title":"J. Autoimmun."},{"issue":"4","key":"10.1016\/j.neuropharm.2024.110217_bib62","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1007\/s10753-021-01439-6","article-title":"The signaling pathways regulating NLRP3 inflammasome activation","volume":"44","author":"Chen","year":"2021","journal-title":"Inflammation"},{"key":"10.1016\/j.neuropharm.2024.110217_bib63","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111442","article-title":"Targeting the NLRP3 inflammasome as new therapeutic avenue for inflammatory bowel disease","volume":"138","author":"Chen","year":"2021","journal-title":"Biomed. Pharmacother."},{"issue":"1","key":"10.1016\/j.neuropharm.2024.110217_bib64","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s11658-023-00462-9","article-title":"The NLRP3 inflammasome: contributions to inflammation-related diseases","volume":"28","author":"Chen","year":"2023","journal-title":"Cell. Mol. Biol. Lett."},{"issue":"1","key":"10.1016\/j.neuropharm.2024.110217_bib65","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/s41392-023-01547-9","article-title":"Mitochondrial dynamics in health and disease: mechanisms and potential targets","volume":"8","author":"Chen","year":"2023","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.neuropharm.2024.110217_bib66","doi-asserted-by":"crossref","first-page":"163","DOI":"10.3389\/fnins.2018.00163","article-title":"The association of tau with mitochondrial dysfunction in Alzheimer's disease","volume":"12","author":"Cheng","year":"2018","journal-title":"Front. Neurosci."},{"issue":"9","key":"10.1016\/j.neuropharm.2024.110217_bib67","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1038\/s41593-022-01140-3","article-title":"Pathological structural conversion of \u03b1-synuclein at the mitochondria induces neuronal toxicity","volume":"25","author":"Choi","year":"2022","journal-title":"Nat. Neurosci."},{"issue":"1","key":"10.1016\/j.neuropharm.2024.110217_bib68","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/s12974-020-01822-4","article-title":"Potential of activated microglia as a source of dysregulated extracellular microRNAs contributing to neurodegeneration in amyotrophic lateral sclerosis","volume":"17","author":"Christoforidou","year":"2020","journal-title":"J. Neuroinflammation"},{"issue":"2","key":"10.1016\/j.neuropharm.2024.110217_bib69","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1021\/acschemneuro.8b00457","article-title":"Pathological changes of tau related to Alzheimer's disease","volume":"10","author":"Chu","year":"2019","journal-title":"ACS Chem. Neurosci."},{"issue":"10","key":"10.1016\/j.neuropharm.2024.110217_bib70","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1038\/ncb2837","article-title":"Cardiolipin externalization to the outer mitochondrial membrane acts as an elimination signal for mitophagy in neuronal cells","volume":"15","author":"Chu","year":"2013","journal-title":"Nat. Cell Biol."},{"issue":"5","key":"10.1016\/j.neuropharm.2024.110217_bib71","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1002\/art.40787","article-title":"Ibudilast inhibits chemokine expression in rheumatoid arthritis synovial fibroblasts and exhibits immunomodulatory activity in experimental arthritis","volume":"71","author":"Clanchy","year":"2019","journal-title":"Arthritis Rheumatol."},{"issue":"6966","key":"10.1016\/j.neuropharm.2024.110217_bib72","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/nature02196","article-title":"TRP channels as cellular sensors","volume":"426","author":"Clapham","year":"2003","journal-title":"Nature"},{"issue":"16","key":"10.1016\/j.neuropharm.2024.110217_bib73","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1002\/cmdc.201600055","article-title":"Design, synthesis, and evaluation of acrylamide derivatives as direct NLRP3 inflammasome inhibitors","volume":"11","author":"Cocco","year":"2016","journal-title":"ChemMedChem"},{"issue":"3","key":"10.1016\/j.neuropharm.2024.110217_bib74","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/nm.3806","article-title":"A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases","volume":"21","author":"Coll","year":"2015","journal-title":"Nat. Med."},{"issue":"6","key":"10.1016\/j.neuropharm.2024.110217_bib75","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/s41589-019-0277-7","article-title":"MCC950 directly targets the NLRP3 ATP-hydrolysis motif for inflammasome inhibition","volume":"15","author":"Coll","year":"2019","journal-title":"Nat. Chem. Biol."},{"issue":"6","key":"10.1016\/j.neuropharm.2024.110217_bib76","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/nri1106","article-title":"TREMs in the immune system and beyond","volume":"3","author":"Colonna","year":"2003","journal-title":"Nat. Rev. Immunol."},{"issue":"9","key":"10.1016\/j.neuropharm.2024.110217_bib77","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1038\/s41577-023-00837-1","article-title":"The biology of TREM receptors","volume":"23","author":"Colonna","year":"2023","journal-title":"Nat. Rev. Immunol."},{"issue":"6477","key":"10.1016\/j.neuropharm.2024.110217_bib78","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1126\/science.aax6752","article-title":"Microglia monitor and protect neuronal function through specialized somatic purinergic junctions","volume":"367","author":"Cser\u00e9p","year":"2020","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.neuropharm.2024.110217_bib79","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.cell.2006.09.015","article-title":"Transcriptional repression of PGC-1alpha by mutant huntingtin leads to mitochondrial dysfunction and neurodegeneration","volume":"127","author":"Cui","year":"2006","journal-title":"Cell"},{"issue":"7","key":"10.1016\/j.neuropharm.2024.110217_bib80","doi-asserted-by":"crossref","first-page":"4648","DOI":"10.4049\/jimmunol.0901212","article-title":"The proinflammatory action of microglial P2 receptors is enhanced in SOD1 models for amyotrophic lateral sclerosis","volume":"183","author":"D'ambrosi","year":"2009","journal-title":"J. Immunol."},{"issue":"5\u20136","key":"10.1016\/j.neuropharm.2024.110217_bib81","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1159\/000501789","article-title":"Upregulation of mitochondrial transcription factor A promotes the repairment of renal tubular epithelial cells in sepsis by inhibiting reactive oxygen species-mediated toll-like receptor 4\/p38MAPK signaling","volume":"86","author":"Dai","year":"2019","journal-title":"Pathobiology"},{"issue":"8","key":"10.1016\/j.neuropharm.2024.110217_bib82","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1056\/NEJMcibr2031048","article-title":"STING-induced inflammation - a novel therapeutic target in ALS?","volume":"384","author":"Van Damme","year":"2021","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.neuropharm.2024.110217_bib83","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1038\/s41467-019-09477-3","article-title":"Different soluble aggregates of A\u03b242 can give rise to cellular toxicity through different mechanisms","volume":"10","author":"De","year":"2019","journal-title":"Nat. Commun."},{"issue":"9","key":"10.1016\/j.neuropharm.2024.110217_bib84","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1038\/s41577-021-00524-z","article-title":"The cGAS-STING pathway as a therapeutic target in inflammatory diseases","volume":"21","author":"Decout","year":"2021","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.neuropharm.2024.110217_bib85","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.mito.2017.12.001","article-title":"Mitochondrial dysfunction and damage associated molecular patterns (DAMPs) in chronic inflammatory diseases","volume":"41","author":"Dela Cruz","year":"2018","journal-title":"Mitochondrion"},{"key":"10.1016\/j.neuropharm.2024.110217_bib86","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/5923938","article-title":"Mitochondrial alterations in peripheral mononuclear blood cells from Alzheimer's disease and mild cognitive impairment patients","volume":"2016","author":"Delbarba","year":"2016","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"2","key":"10.1016\/j.neuropharm.2024.110217_bib87","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1002\/glia.23728","article-title":"The microglial NLRP3 inflammasome is activated by amyotrophic lateral sclerosis proteins","volume":"68","author":"Deora","year":"2020","journal-title":"Glia"},{"issue":"9","key":"10.1016\/j.neuropharm.2024.110217_bib88","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.110883","article-title":"Sustained Trem2 stabilization accelerates microglia heterogeneity and A\u03b2 pathology in a mouse model of Alzheimer's disease","volume":"39","author":"Dhandapani","year":"2022","journal-title":"Cell Rep."},{"issue":"1","key":"10.1016\/j.neuropharm.2024.110217_bib89","doi-asserted-by":"crossref","first-page":"3","DOI":"10.4161\/mabs.2.1.10328","article-title":"Canakinumab","volume":"2","author":"Dhimolea","year":"2010","journal-title":"mAbs"},{"issue":"7717","key":"10.1016\/j.neuropharm.2024.110217_bib90","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1038\/s41586-018-0363-0","article-title":"Mitochondrial double-stranded RNA triggers antiviral signalling in humans","volume":"560","author":"Dhir","year":"2018","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.neuropharm.2024.110217_bib91","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1016\/j.neurobiolaging.2011.09.040","article-title":"In vivo P2X7 inhibition reduces amyloid plaques in Alzheimer's disease through GSK3\u03b2 and secretases","volume":"33","author":"Diaz-Hernandez","year":"2012","journal-title":"Neurobiol. Aging"},{"issue":"6","key":"10.1016\/j.neuropharm.2024.110217_bib92","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.smim.2013.10.008","article-title":"Treating inflammation by blocking interleukin-1 in humans","volume":"25","author":"Dinarello","year":"2013","journal-title":"Semin. Immunol."},{"issue":"8","key":"10.1016\/j.neuropharm.2024.110217_bib93","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1038\/nrd3800","article-title":"Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases","volume":"11","author":"Dinarello","year":"2012","journal-title":"Nat. Rev. Drug Discov."},{"issue":"6","key":"10.1016\/j.neuropharm.2024.110217_bib94","doi-asserted-by":"crossref","DOI":"10.3390\/cells11061049","article-title":"Predicting mitochondrial dynamic behavior in genetically defined neurodegenerative diseases","volume":"11","author":"Dorn","year":"2022","journal-title":"Cells"},{"issue":"11","key":"10.1016\/j.neuropharm.2024.110217_bib95","doi-asserted-by":"crossref","DOI":"10.3390\/jcm10112235","article-title":"Myasthenia gravis: epidemiology, pathophysiology and clinical manifestations","volume":"10","author":"Dresser","year":"2021","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.neuropharm.2024.110217_bib96","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/bs.ai.2017.05.006","article-title":"P2Y receptors in immune response and inflammation","volume":"136","author":"Le Duc","year":"2017","journal-title":"Adv. Immunol."},{"issue":"1","key":"10.1016\/j.neuropharm.2024.110217_bib97","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/boc.201400043","article-title":"P2Y receptors in Alzheimer's disease","volume":"107","author":"Erb","year":"2015","journal-title":"Biol. Cell."},{"issue":"4","key":"10.1016\/j.neuropharm.2024.110217_bib98","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.tem.2021.01.006","article-title":"Cardiolipin, mitochondria, and neurological disease","volume":"32","author":"Falabella","year":"2021","journal-title":"Trends Endocrinol. Metabol."},{"issue":"3","key":"10.1016\/j.neuropharm.2024.110217_bib99","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1002\/glia.22437","article-title":"Toll-like receptor 4 is required for \u03b1-synuclein dependent activation of microglia and astroglia","volume":"61","author":"Fellner","year":"2013","journal-title":"Glia"},{"key":"10.1016\/j.neuropharm.2024.110217_bib100","doi-asserted-by":"crossref","first-page":"769","DOI":"10.3389\/fnins.2019.00769","article-title":"Therapeutic effect of modulating TREM-1 via anti-inflammation and autophagy in Parkinson's disease","volume":"13","author":"Feng","year":"2019","journal-title":"Front. Neurosci."},{"issue":"1","key":"10.1016\/j.neuropharm.2024.110217_bib101","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.nbd.2006.06.013","article-title":"Progressive neurodegeneration and motor disabilities induced by chronic expression of IL-1beta in the substantia nigra","volume":"24","author":"Ferrari","year":"2006","journal-title":"Neurobiol. Dis."},{"issue":"Suppl. 2","key":"10.1016\/j.neuropharm.2024.110217_bib102","doi-asserted-by":"crossref","first-page":"S369","DOI":"10.3233\/JAD-2010-100543","article-title":"Mitochondria and the link between neuroinflammation and neurodegeneration","volume":"20","author":"Di Filippo","year":"2010","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"10.1016\/j.neuropharm.2024.110217_bib103","doi-asserted-by":"crossref","first-page":"3916","DOI":"10.1038\/s41467-018-06449-x","article-title":"Caspase-1 inhibition alleviates cognitive impairment and neuropathology in an Alzheimer's disease mouse model","volume":"9","author":"Flores","year":"2018","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.neuropharm.2024.110217_bib104","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1038\/sj.bjp.0705914","article-title":"TRPM2 channel opening in response to oxidative stress is dependent on activation of poly(ADP-ribose) polymerase","volume":"143","author":"Fonfria","year":"2004","journal-title":"Br. J. Pharmacol."},{"issue":"3","key":"10.1016\/j.neuropharm.2024.110217_bib105","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1111\/j.1471-4159.2005.03396.x","article-title":"Amyloid beta-peptide(1-42) and hydrogen peroxide-induced toxicity are mediated by TRPM2 in rat primary striatal cultures","volume":"95","author":"Fonfria","year":"2005","journal-title":"J. Neurochem."},{"issue":"9","key":"10.1016\/j.neuropharm.2024.110217_bib106","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1056\/NEJMoa1803583","article-title":"Phase 2 trial of ibudilast in progressive multiple sclerosis","volume":"379","author":"Fox","year":"2018","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.neuropharm.2024.110217_bib107","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/j.neuron.2014.01.013","article-title":"Microglia induce motor neuron death via the classical NF-\u03baB pathway in amyotrophic lateral sclerosis","volume":"81","author":"Frakes","year":"2014","journal-title":"Neuron"},{"issue":"12","key":"10.1016\/j.neuropharm.2024.110217_bib108","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.tibs.2011.08.008","article-title":"RAGE: a single receptor fits multiple ligands","volume":"36","author":"Fritz","year":"2011","journal-title":"Trends Biochem. Sci."},{"issue":"11","key":"10.1016\/j.neuropharm.2024.110217_bib109","doi-asserted-by":"crossref","first-page":"8586","DOI":"10.3390\/cimb45110540","article-title":"Mitochondrial DNA and inflammation in Alzheimer's disease","volume":"45","author":"Galizzi","year":"2023","journal-title":"Curr. Issues Mol. Biol."},{"issue":"4","key":"10.1016\/j.neuropharm.2024.110217_bib110","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.rcl.2008.06.002","article-title":"Neurodegenerative diseases","volume":"46","author":"Gallucci","year":"2008","journal-title":"Radiol. Clin."},{"issue":"12","key":"10.1016\/j.neuropharm.2024.110217_bib111","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1038\/nrm3479","article-title":"Mitochondria: master regulators of danger signalling","volume":"13","author":"Galluzzi","year":"2012","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"2","key":"10.1016\/j.neuropharm.2024.110217_bib112","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/j.1601-183X.2009.00542.x","article-title":"MitoPark mice mirror the slow progression of key symptoms and L-DOPA response in Parkinson's disease","volume":"9","author":"Galter","year":"2010","journal-title":"Gene Brain Behav."},{"key":"10.1016\/j.neuropharm.2024.110217_bib113","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.3389\/fimmu.2019.01064","article-title":"Ccf-mtDNA as a potential link between the brain and immune system in neuro-immunological disorders","volume":"10","author":"Gambardella","year":"2019","journal-title":"Front. Immunol."},{"issue":"5558","key":"10.1016\/j.neuropharm.2024.110217_bib114","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1126\/science.1067289","article-title":"MAPKK-independent activation of p38alpha mediated by TAB1-dependent autophosphorylation of p38alpha","volume":"295","author":"Ge","year":"2002","journal-title":"Science"},{"issue":"8","key":"10.1016\/j.neuropharm.2024.110217_bib115","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/s41582-019-0227-8","article-title":"Neuroinflammation - a common thread in neurological disorders","volume":"15","author":"Gilhus","year":"2019","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.neuropharm.2024.110217_bib116","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1146\/annurev.bi.56.070187.003151","article-title":"G proteins: transducers of receptor-generated signals","volume":"56","author":"Gilman","year":"1987","journal-title":"Annu. Rev. Biochem."},{"issue":"6","key":"10.1016\/j.neuropharm.2024.110217_bib117","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.cell.2010.02.016","article-title":"Mechanisms underlying inflammation in neurodegeneration","volume":"140","author":"Glass","year":"2010","journal-title":"Cell"},{"issue":"22","key":"10.1016\/j.neuropharm.2024.110217_bib118","doi-asserted-by":"crossref","first-page":"3564","DOI":"10.4161\/cc.7.22.7073","article-title":"SNP-guided microRNA maps (MirMaps) of 16 common human disorders identify a clinically accessible therapy reversing transcriptional aberrations of nuclear import and inflammasome pathways","volume":"7","author":"Glinsky","year":"2008","journal-title":"Cell Cycle"},{"issue":"3","key":"10.1016\/j.neuropharm.2024.110217_bib119","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.ncl.2006.03.010","article-title":"Age and neuroinflammation: a lifetime of psychoneuroimmune consequences","volume":"24","author":"Godbout","year":"2006","journal-title":"Neurol. Clin."},{"issue":"7","key":"10.1016\/j.neuropharm.2024.110217_bib120","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/35081564","article-title":"Alpha-synuclein and neurodegenerative diseases","volume":"2","author":"Goedert","year":"2001","journal-title":"Nat. Rev. Neurosci."},{"issue":"2","key":"10.1016\/j.neuropharm.2024.110217_bib121","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/s41577-019-0215-7","article-title":"DAMP-sensing receptors in sterile inflammation and inflammatory diseases","volume":"20","author":"Gong","year":"2020","journal-title":"Nat. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.neuropharm.2024.110217_bib122","first-page":"281","article-title":"Inhibition of TLR4\/TRIF\/IRF3 signaling pathway by curcumin in breast cancer cells","volume":"22","author":"G\u00fcney","year":"2019","journal-title":"J. Pharm. Pharmaceut. Sci."},{"issue":"7973","key":"10.1016\/j.neuropharm.2024.110217_bib123","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1038\/s41586-023-06373-1","article-title":"cGAS-STING drives ageing-related inflammation and neurodegeneration","volume":"620","author":"Gulen","year":"2023","journal-title":"Nature"},{"issue":"7973","key":"10.1016\/j.neuropharm.2024.110217_bib124","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1038\/s41586-023-06373-1","article-title":"cGAS-STING drives ageing-related inflammation and neurodegeneration Signaling by cGAS-STING in Neurodegeneration, Neuroinflammation, and Aging","volume":"620","author":"Gulen","year":"2023","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.neuropharm.2024.110217_bib125","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/nm.3893","article-title":"Inflammasomes: mechanism of action, role in disease, and therapeutics","volume":"21","author":"Guo","year":"2015","journal-title":"Nat. Med."},{"issue":"11","key":"10.1016\/j.neuropharm.2024.110217_bib126","doi-asserted-by":"crossref","first-page":"12164","DOI":"10.1096\/fj.201900992R","article-title":"TREM2 deficiency aggravates \u03b1-synuclein-induced neurodegeneration and neuroinflammation in Parkinson's disease models","volume":"33","author":"Guo","year":"2019","journal-title":"Faseb. J."},{"key":"10.1016\/j.neuropharm.2024.110217_bib127","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2022.815347","article-title":"Microglia polarization from M1 to M2 in neurodegenerative diseases","volume":"14","author":"Guo","year":"2022","journal-title":"Front. Aging Neurosci."},{"issue":"7713","key":"10.1016\/j.neuropharm.2024.110217_bib128","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41586-018-0287-8","article-title":"Targeting STING with covalent small-molecule inhibitors","volume":"559","author":"Haag","year":"2018","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.neuropharm.2024.110217_bib129","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0184843","article-title":"Discovery of PF-06928215 as a high affinity inhibitor of cGAS enabled by a novel fluorescence polarization assay","volume":"12","author":"Hall","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2024.110217_bib130","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/978-3-319-41523-9_15","article-title":"Adhesion GPCRs as modulators of immune cell function","volume":"234","author":"Hamann","year":"2016","journal-title":"Handb. Exp. Pharmacol."},{"issue":"2","key":"10.1016\/j.neuropharm.2024.110217_bib131","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1074\/jbc.273.2.669","article-title":"The many faces of G protein signaling","volume":"273","author":"Hamm","year":"1998","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.neuropharm.2024.110217_bib132","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.immuni.2019.03.016","article-title":"Immune signaling in neurodegeneration","volume":"50","author":"Hammond","year":"2019","journal-title":"Immunity"},{"issue":"33","key":"10.1016\/j.neuropharm.2024.110217_bib133","doi-asserted-by":"crossref","first-page":"E7768","DOI":"10.1073\/pnas.1806239115","article-title":"Nitro-fatty acids are formed in response to virus infection and are potent inhibitors of STING palmitoylation and signaling","volume":"115","author":"Hansen","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"11","key":"10.1016\/j.neuropharm.2024.110217_bib134","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/nrneurol.2011.153","article-title":"Clinical diagnosis and management of amyotrophic lateral sclerosis","volume":"7","author":"Hardiman","year":"2011","journal-title":"Nat. Rev. Neurol."},{"issue":"7","key":"10.1016\/j.neuropharm.2024.110217_bib135","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.tcb.2013.02.002","article-title":"Evaluating and responding to mitochondrial dysfunction: the mitochondrial unfolded-protein response and beyond","volume":"23","author":"Haynes","year":"2013","journal-title":"Trends Cell Biol."},{"issue":"7628","key":"10.1016\/j.neuropharm.2024.110217_bib136","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/539179a","article-title":"Neurodegenerative diseases","volume":"539","author":"Heemels","year":"2016","journal-title":"Nature"},{"issue":"6813","key":"10.1016\/j.neuropharm.2024.110217_bib137","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/35047123","article-title":"A Toll-like receptor recognizes bacterial DNA","volume":"408","author":"Hemmi","year":"2000","journal-title":"Nature"},{"issue":"15","key":"10.1016\/j.neuropharm.2024.110217_bib138","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2118819119","article-title":"STING mediates neurodegeneration and neuroinflammation in nigrostriatal \u03b1-synucleinopathy","volume":"119","author":"Hinkle","year":"2022","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"6","key":"10.1016\/j.neuropharm.2024.110217_bib139","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1038\/s41569-018-0145-2","article-title":"Transient receptor potential channels in cardiac health and disease","volume":"16","author":"Hof","year":"2019","journal-title":"Nat. Rev. Cardiol."},{"issue":"9","key":"10.1016\/j.neuropharm.2024.110217_bib140","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1038\/nri1900","article-title":"IRFs: master regulators of signalling by Toll-like receptors and cytosolic pattern-recognition receptors","volume":"6","author":"Honda","year":"2006","journal-title":"Nat. Rev. Immunol."},{"issue":"9","key":"10.1016\/j.neuropharm.2024.110217_bib141","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/s41580-020-0244-x","article-title":"Molecular mechanisms and cellular functions of cGAS-STING signalling","volume":"21","author":"Hopfner","year":"2020","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"8","key":"10.1016\/j.neuropharm.2024.110217_bib142","doi-asserted-by":"crossref","first-page":"E1876","DOI":"10.1073\/pnas.1718819115","article-title":"NAD(+) supplementation normalizes key Alzheimer's features and DNA damage responses in a new AD mouse model with introduced DNA repair deficiency","volume":"115","author":"Hou","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"10","key":"10.1016\/j.neuropharm.2024.110217_bib143","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/s41582-019-0244-7","article-title":"Ageing as a risk factor for neurodegenerative disease","volume":"15","author":"Hou","year":"2019","journal-title":"Nat. Rev. Neurol."},{"issue":"37","key":"10.1016\/j.neuropharm.2024.110217_bib144","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2011226118","article-title":"NAD(+) supplementation reduces neuroinflammation and cell senescence in a transgenic mouse model of Alzheimer's disease via cGAS-STING","volume":"118","author":"Hou","year":"2021","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2024.110217_bib145","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.106824","article-title":"Transient receptor potential melastatin 2 contributes to neuroinflammation and negatively regulates cognitive outcomes in a pilocarpine-induced mouse model of epilepsy","volume":"87","author":"Hu","year":"2020","journal-title":"Int. Immunopharm."},{"issue":"9","key":"10.1016\/j.neuropharm.2024.110217_bib146","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1038\/s41423-021-00740-6","article-title":"NLRP3 inflammasome activation and cell death","volume":"18","author":"Huang","year":"2021","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.neuropharm.2024.110217_bib147","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1146\/annurev-med-041316-085215","article-title":"Targeting RAGE signaling in inflammatory disease","volume":"69","author":"Hudson","year":"2018","journal-title":"Annu. Rev. Med."},{"issue":"1","key":"10.1016\/j.neuropharm.2024.110217_bib148","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/s42003-020-0792-9","article-title":"Beta amyloid aggregates induce sensitised TLR4 signalling causing long-term potentiation deficit and rat neuronal cell death","volume":"3","author":"Hughes","year":"2020","journal-title":"Commun. Biol."},{"issue":"Pt 1","key":"10.1016\/j.neuropharm.2024.110217_bib149","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1101\/SQB.1989.054.01.003","article-title":"Approaching the asymptote? Evolution and revolution in immunology","volume":"54","author":"Janeway","year":"1989","journal-title":"Cold Spring Harbor Symp. Quant. Biol."},{"key":"10.1016\/j.neuropharm.2024.110217_bib150","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1146\/annurev.immunol.20.083001.084359","article-title":"Innate immune recognition","volume":"20","author":"Janeway","year":"2002","journal-title":"Annu. Rev. Immunol."},{"issue":"6","key":"10.1016\/j.neuropharm.2024.110217_bib151","doi-asserted-by":"crossref","first-page":"3124","DOI":"10.1172\/JCI135026","article-title":"Melatonin inhibits cytosolic mitochondrial DNA-induced neuroinflammatory signaling in accelerated aging and neurodegeneration","volume":"130","author":"Jauhari","year":"2020","journal-title":"J. Clin. Invest."},{"issue":"11","key":"10.1016\/j.neuropharm.2024.110217_bib152","doi-asserted-by":"crossref","first-page":"3219","DOI":"10.1084\/jem.20171419","article-title":"Identification of a selective and direct NLRP3 inhibitor to treat inflammatory disorders","volume":"214","author":"Jiang","year":"2017","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.neuropharm.2024.110217_bib153","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.neulet.2018.02.049","article-title":"RAGE and its emerging role in the pathogenesis of Parkinson's disease","volume":"672","author":"Jiang","year":"2018","journal-title":"Neurosci. Lett."},{"issue":"8","key":"10.1016\/j.neuropharm.2024.110217_bib154","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1010796","article-title":"Succinate and inosine coordinate innate immune response to bacterial infection","volume":"18","author":"Jiang","year":"2022","journal-title":"PLoS Pathog."},{"issue":"7","key":"10.1016\/j.neuropharm.2024.110217_bib155","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a024240","article-title":"Huntington's disease: mechanisms of pathogenesis and therapeutic strategies","volume":"7","author":"Jimenez-Sanchez","year":"2017","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"5600","key":"10.1016\/j.neuropharm.2024.110217_bib156","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1126\/science.1072682","article-title":"Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases","volume":"298","author":"Johnson","year":"2002","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.neuropharm.2024.110217_bib157","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1056\/NEJMoa1211103","article-title":"Variant of TREM2 associated with the risk of Alzheimer's disease","volume":"368","author":"Jonsson","year":"2013","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.neuropharm.2024.110217_bib158","doi-asserted-by":"crossref","first-page":"433","DOI":"10.4049\/jimmunol.1101375","article-title":"Mitochondrial transcription factor A serves as a danger signal by augmenting plasmacytoid dendritic cell responses to DNA","volume":"189","author":"Julian","year":"2012","journal-title":"J. Immunol."},{"issue":"8","key":"10.1016\/j.neuropharm.2024.110217_bib159","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22083875","article-title":"The links between ALS and NF-\u03baB","volume":"22","author":"K\u00e4llstig","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.neuropharm.2024.110217_bib160","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/nchembio727","article-title":"Cytochrome c acts as a cardiolipin oxygenase required for release of proapoptotic factors","volume":"1","author":"Kagan","year":"2005","journal-title":"Nat. Chem. Biol."},{"issue":"4","key":"10.1016\/j.neuropharm.2024.110217_bib161","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/ni1569","article-title":"TRAM couples endocytosis of Toll-like receptor 4 to the induction of interferon-beta","volume":"9","author":"Kagan","year":"2008","journal-title":"Nat. Immunol."},{"issue":"10","key":"10.1016\/j.neuropharm.2024.110217_bib162","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1111\/bph.12414","article-title":"Transient receptor potential (TRP) channels: a clinical perspective","volume":"171","author":"Kaneko","year":"2014","journal-title":"Br. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.neuropharm.2024.110217_bib163","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1254\/jphs.FP0060128","article-title":"A critical role of TRPM2 in neuronal cell death by hydrogen peroxide","volume":"101","author":"Kaneko","year":"2006","journal-title":"J. Pharmacol. Sci."},{"issue":"Pt A","key":"10.1016\/j.neuropharm.2024.110217_bib164","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.arr.2015.02.005","article-title":"Innate immune perturbations, accumulating DAMPs and inflammasome dysregulation: a ticking time bomb in ageing","volume":"24","author":"Kapetanovic","year":"2015","journal-title":"Ageing Res. Rev."},{"issue":"1","key":"10.1016\/j.neuropharm.2024.110217_bib165","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s12865-016-0147-y","article-title":"Double-stranded RNA analog and type I interferon regulate expression of Trem paired receptors in murine myeloid cells","volume":"17","author":"Kasamatsu","year":"2016","journal-title":"BMC Immunol."},{"issue":"5","key":"10.1016\/j.neuropharm.2024.110217_bib166","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/ni.1863","article-title":"The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors","volume":"11","author":"Kawai","year":"2010","journal-title":"Nat. Immunol."},{"issue":"1","key":"10.1016\/j.neuropharm.2024.110217_bib167","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.ejphar.2008.01.026","article-title":"TAK-242 selectively suppresses Toll-like receptor 4-signaling mediated by the intracellular domain","volume":"584","author":"Kawamoto","year":"2008","journal-title":"Eur. J. Pharmacol."},{"issue":"7102","key":"10.1016\/j.neuropharm.2024.110217_bib168","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1038\/nature04886","article-title":"P2X receptors as cell-surface ATP sensors in health and disease","volume":"442","author":"Khakh","year":"2006","journal-title":"Nature"},{"issue":"9769","key":"10.1016\/j.neuropharm.2024.110217_bib169","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/S0140-6736(10)61156-7","article-title":"Amyotrophic lateral sclerosis","volume":"377","author":"Kiernan","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.neuropharm.2024.110217_bib170","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.expneurol.2014.01.001","article-title":"Pattern recognition receptors and central nervous system repair","volume":"258","author":"Kigerl","year":"2014","journal-title":"Exp. Neurol."},{"issue":"16","key":"10.1016\/j.neuropharm.2024.110217_bib171","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22168363","article-title":"New avenues for the treatment of Huntington's disease","volume":"22","author":"Kim","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.neuropharm.2024.110217_bib172","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1038\/s12276-023-00965-7","article-title":"Molecular mechanisms of mitochondrial DNA release and activation of the cGAS-STING pathway","volume":"55","author":"Kim","year":"2023","journal-title":"Exp. Mol. Med."},{"issue":"1","key":"10.1016\/j.neuropharm.2024.110217_bib173","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/s12979-023-00383-3","article-title":"Toll-like receptor 4 (TLR4): new insight immune and aging TLR4 signaling: a potential therapeutic target in ischemic coronary artery disease","volume":"20","author":"Kim","year":"2023","journal-title":"Immun. Ageing"},{"issue":"6","key":"10.1016\/j.neuropharm.2024.110217_bib174","doi-asserted-by":"crossref","first-page":"853","DOI":"10.4093\/dmj.2021.0138","article-title":"Mitochondrial TFAM as a signaling regulator between cellular organelles: a perspective on metabolic diseases","volume":"45","author":"Koh","year":"2021","journal-title":"Diabetes Metab. J"},{"issue":"8","key":"10.1016\/j.neuropharm.2024.110217_bib175","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1001\/jamaneurol.2015.0979","article-title":"R47H variant of TREM2 associated with alzheimer disease in a large late-onset family: clinical, genetic, and neuropathological study","volume":"72","author":"Korvatska","year":"2015","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.neuropharm.2024.110217_bib176","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/B978-0-12-802395-2.00021-3","article-title":"Concepts and classification of neurodegenerative diseases","volume":"145","author":"Kovacs","year":"2017","journal-title":"Handb. Clin. Neurol."},{"issue":"1","key":"10.1016\/j.neuropharm.2024.110217_bib177","doi-asserted-by":"crossref","first-page":"C129","DOI":"10.1152\/ajpcell.00331.2003","article-title":"Hydrogen peroxide and ADP-ribose induce TRPM2-mediated calcium influx and cation currents in microglia","volume":"286","author":"Kraft","year":"2004","journal-title":"Am. J. Physiol. Cell Physiol."},{"issue":"12","key":"10.1016\/j.neuropharm.2024.110217_bib178","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/nrc3380","article-title":"Immunogenic cell death and DAMPs in cancer therapy","volume":"12","author":"Krysko","year":"2012","journal-title":"Nat. Rev. Cancer"},{"issue":"6482","key":"10.1016\/j.neuropharm.2024.110217_bib179","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1038\/369621a0","article-title":"Structural determinants for activation of the alpha-subunit of a heterotrimeric G protein","volume":"369","author":"Lambright","year":"1994","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.neuropharm.2024.110217_bib180","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/s41435-023-00198-8","article-title":"Role of DAMPs and cell death in autoimmune diseases: the example of multiple sclerosis","volume":"24","author":"Land","year":"2023","journal-title":"Gene Immun."},{"issue":"3","key":"10.1016\/j.neuropharm.2024.110217_bib181","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/ng0398-231","article-title":"Mitochondrial transcription factor A is necessary for mtDNA maintenance and embryogenesis in mice","volume":"18","author":"Larsson","year":"1998","journal-title":"Nat. Genet."},{"issue":"7","key":"10.1016\/j.neuropharm.2024.110217_bib182","doi-asserted-by":"crossref","DOI":"10.3390\/biom10071036","article-title":"Deoxyribonucleases and their applications in biomedicine","volume":"10","author":"Laukov\u00e1","year":"2020","journal-title":"Biomolecules"},{"key":"10.1016\/j.neuropharm.2024.110217_bib183","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-1-0716-3350-2_1","article-title":"Canonical inflammasomes","volume":"2696","author":"Leal","year":"2023","journal-title":"Methods Mol. Biol."},{"issue":"11","key":"10.1016\/j.neuropharm.2024.110217_bib184","doi-asserted-by":"crossref","first-page":"e920","DOI":"10.1038\/cddis.2013.449","article-title":"Smac mimetics induce inflammation and necrotic tumour cell death by modulating macrophage activity","volume":"4","author":"Lecis","year":"2013","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.neuropharm.2024.110217_bib185","doi-asserted-by":"crossref","DOI":"10.1155\/2010\/539581","article-title":"The S100B\/RAGE Axis in Alzheimer's disease","volume":"2010","author":"Leclerc","year":"2010","journal-title":"Cardiovasc Psychiatry Neurol"},{"issue":"1","key":"10.1016\/j.neuropharm.2024.110217_bib186","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3899\/jrheum.090450","article-title":"Serum BLC\/CXCL13 concentrations and renal expression of CXCL13\/CXCR5 in patients with systemic lupus erythematosus and lupus nephritis","volume":"37","author":"Lee","year":"2010","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.neuropharm.2024.110217_bib187","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s12974-015-0310-z","article-title":"Absence of toll-like receptor 4 (TLR4) extends survival in the hSOD1 G93A mouse model of amyotrophic lateral sclerosis","volume":"12","author":"Lee","year":"2015","journal-title":"J. Neuroinflammation"},{"issue":"2","key":"10.1016\/j.neuropharm.2024.110217_bib188","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.4049\/jimmunol.173.2.1179","article-title":"TLR9 is localized in the endoplasmic reticulum prior to stimulation","volume":"173","author":"Leifer","year":"2004","journal-title":"J. Immunol."},{"key":"10.1016\/j.neuropharm.2024.110217_bib189","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-94-024-1088-4_1","article-title":"TRP channel classification","volume":"976","author":"Li","year":"2017","journal-title":"Adv. Exp. Med. Biol."},{"issue":"3","key":"10.1016\/j.neuropharm.2024.110217_bib190","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0304-3940(97)00266-8","article-title":"Enhanced binding of advanced glycation endproducts (AGE) by the ApoE4 isoform links the mechanism of plaque deposition in Alzheimer's disease","volume":"226","author":"Li","year":"1997","journal-title":"Neurosci. Lett."},{"issue":"26","key":"10.1016\/j.neuropharm.2024.110217_bib191","doi-asserted-by":"crossref","first-page":"16498","DOI":"10.1074\/jbc.272.26.16498","article-title":"Characterization and functional analysis of the promoter of RAGE, the receptor for advanced glycation end products","volume":"272","author":"Li","year":"1997","journal-title":"J. Biol. Chem."},{"issue":"7","key":"10.1016\/j.neuropharm.2024.110217_bib192","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1007\/s00109-013-1005-5","article-title":"Molecular biology for formyl peptide receptors in human diseases","volume":"91","author":"Li","year":"2013","journal-title":"J. Mol. Med. (Berl.)"},{"issue":"6","key":"10.1016\/j.neuropharm.2024.110217_bib193","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/j.immuni.2013.10.019","article-title":"Cyclic GMP-AMP synthase is activated by double-stranded DNA-induced oligomerization","volume":"39","author":"Li","year":"2013","journal-title":"Immunity"},{"issue":"12","key":"10.1016\/j.neuropharm.2024.110217_bib194","doi-asserted-by":"crossref","first-page":"3405","DOI":"10.1016\/j.celrep.2018.11.097","article-title":"The cyclopeptide astin C specifically inhibits the innate immune CDN sensor STING","volume":"25","author":"Li","year":"2018","journal-title":"Cell Rep."},{"issue":"3","key":"10.1016\/j.neuropharm.2024.110217_bib195","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.108631","article-title":"The mitochondrial protein ERAL1 suppresses RNA virus infection by facilitating RIG-I-like receptor signaling","volume":"34","author":"Li","year":"2021","journal-title":"Cell Rep."},{"key":"10.1016\/j.neuropharm.2024.110217_bib196","article-title":"Therapeutic development by targeting the cGAS-STING pathway in autoimmune disease and cancer","volume":"12","author":"Li","year":"2021","journal-title":"Front. Pharmacol."},{"issue":"4","key":"10.1016\/j.neuropharm.2024.110217_bib197","doi-asserted-by":"crossref","first-page":"307","DOI":"10.3892\/etm.2022.11236","article-title":"Mitochondrial dynamics and biogenesis indicators may serve as potential biomarkers for diagnosis of myasthenia gravis","volume":"23","author":"Li","year":"2022","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.neuropharm.2024.110217_bib198","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2022.175091","article-title":"Therapeutic potential of MCC950, a specific inhibitor of NLRP3 inflammasome","volume":"928","author":"Li","year":"2022","journal-title":"Eur. J. Pharmacol."},{"issue":"7113","key":"10.1016\/j.neuropharm.2024.110217_bib199","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/nature05292","article-title":"Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases","volume":"443","author":"Lin","year":"2006","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.neuropharm.2024.110217_bib200","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.cell.2004.09.013","article-title":"Defects in adaptive energy metabolism with CNS-linked hyperactivity in PGC-1alpha null mice","volume":"119","author":"Lin","year":"2004","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.neuropharm.2024.110217_bib201","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1038\/ki.2013.11","article-title":"The TLR4 antagonist CRX-526 protects against advanced diabetic nephropathy","volume":"83","author":"Lin","year":"2013","journal-title":"Kidney Int."},{"issue":"10","key":"10.1016\/j.neuropharm.2024.110217_bib202","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1038\/s41401-022-00879-6","article-title":"Mitochondrial-derived damage-associated molecular patterns amplify neuroinflammation in neurodegenerative diseases","volume":"43","author":"Lin","year":"2022","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.neuropharm.2024.110217_bib203","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.cotox.2017.11.002","article-title":"NF-\u03baB in oxidative stress","volume":"7","author":"Lingappan","year":"2018","journal-title":"Curr Opin Toxicol"},{"key":"10.1016\/j.neuropharm.2024.110217_bib204","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.neulet.2013.04.049","article-title":"Association of P2X7 receptor gene polymorphisms with sporadic Parkinson's disease in a Han Chinese population","volume":"546","author":"Liu","year":"2013","journal-title":"Neurosci. Lett."},{"issue":"6227","key":"10.1016\/j.neuropharm.2024.110217_bib205","doi-asserted-by":"crossref","first-page":"aaa2630","DOI":"10.1126\/science.aaa2630","article-title":"Phosphorylation of innate immune adaptor proteins MAVS, STING, and TRIF induces IRF3 activation","volume":"347","author":"Liu","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2024.110217_bib206","article-title":"CpG methylation patterns of human mitochondrial DNA","volume":"6","author":"Liu","year":"2016","journal-title":"Sci. Rep."},{"issue":"35","key":"10.1016\/j.neuropharm.2024.110217_bib207","doi-asserted-by":"crossref","first-page":"23944","DOI":"10.18632\/oncotarget.24050","article-title":"MicroRNA-146a suppresses rheumatoid arthritis fibroblast-like synoviocytes proliferation and inflammatory responses by inhibiting the TLR4\/NF-kB signaling","volume":"9","author":"Liu","year":"2018","journal-title":"Oncotarget"},{"issue":"10","key":"10.1016\/j.neuropharm.2024.110217_bib208","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22105260","article-title":"G-protein coupled receptors (GPCRs): signaling pathways, characterization, and functions in insect physiology and toxicology","volume":"22","author":"Liu","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuropharm.2024.110217_bib209","article-title":"The cGAS-STING pathway in bacterial infection and bacterial immunity","volume":"12","author":"Liu","year":"2021","journal-title":"Front. Immunol."},{"issue":"50","key":"10.1016\/j.neuropharm.2024.110217_bib210","doi-asserted-by":"crossref","first-page":"32145","DOI":"10.1073\/pnas.2009680117","article-title":"The NLRP3 inflammasome inhibitor OLT1177 rescues cognitive impairment in a mouse model of Alzheimer's disease","volume":"117","author":"Lonnemann","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"8","key":"10.1016\/j.neuropharm.2024.110217_bib211","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1590\/S0100-879X2003000800004","article-title":"Endothelial cells, tissue factor and infectious diseases","volume":"36","author":"Lopes-Bezerra","year":"2003","journal-title":"Braz. J. Med. Biol. Res."},{"issue":"1","key":"10.1016\/j.neuropharm.2024.110217_bib212","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s13024-020-00362-y","article-title":"Circulating cell-free mitochondrial DNA levels in Parkinson's disease are influenced by treatment","volume":"15","author":"Lowes","year":"2020","journal-title":"Mol. Neurodegener."},{"issue":"1","key":"10.1016\/j.neuropharm.2024.110217_bib213","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1006\/exnr.2001.7732","article-title":"Involvement of microglial receptor for advanced glycation endproducts (RAGE) in Alzheimer's disease: identification of a cellular activation mechanism","volume":"171","author":"Lue","year":"2001","journal-title":"Exp. Neurol."},{"issue":"4","key":"10.1016\/j.neuropharm.2024.110217_bib214","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.nurt.2010.05.014","article-title":"Microglial activation and chronic neurodegeneration","volume":"7","author":"Lull","year":"2010","journal-title":"Neurotherapeutics"},{"issue":"1","key":"10.1016\/j.neuropharm.2024.110217_bib215","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/s41423-023-01112-y","article-title":"The BCL-2 inhibitor APG-2575 resets tumor-associated macrophages toward the M1 phenotype, promoting a favorable response to anti-PD-1 therapy via NLRP3 activation","volume":"21","author":"Luo","year":"2024","journal-title":"Cell. Mol. Immunol."},{"issue":"5","key":"10.1016\/j.neuropharm.2024.110217_bib216","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s00395-007-0666-z","article-title":"Excitation-contraction coupling and mitochondrial energetics","volume":"102","author":"Maack","year":"2007","journal-title":"Basic Res. Cardiol."},{"issue":"2","key":"10.1016\/j.neuropharm.2024.110217_bib217","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.immuni.2017.07.011","article-title":"Nlrp6- and ASC-dependent inflammasomes do not shape the commensal gut microbiota composition","volume":"47","author":"Mamantopoulos","year":"2017","journal-title":"Immunity"},{"issue":"6","key":"10.1016\/j.neuropharm.2024.110217_bib218","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1007\/s00702-010-0400-0","article-title":"On the role of P2X(7) receptors in dopamine nerve cell degeneration in a rat model of Parkinson's disease: studies with the P2X(7) receptor antagonist A-438079","volume":"117","author":"Marcellino","year":"2010","journal-title":"J. Neural. Transm."},{"issue":"7","key":"10.1016\/j.neuropharm.2024.110217_bib219","doi-asserted-by":"crossref","first-page":"E1530","DOI":"10.1073\/pnas.1716095115","article-title":"OLT1177, a \u03b2-sulfonyl nitrile compound, safe in humans, inhibits the NLRP3 inflammasome and reverses the metabolic cost of inflammation","volume":"115","author":"Marchetti","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"2","key":"10.1016\/j.neuropharm.2024.110217_bib220","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s00281-016-0581-1","article-title":"The role of NLRP3 and AIM2 in inflammasome activation during Brucella abortus infection","volume":"39","author":"Marim","year":"2017","journal-title":"Semin. Immunopathol."},{"issue":"2","key":"10.1016\/j.neuropharm.2024.110217_bib221","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S1097-2765(02)00599-3","article-title":"The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta","volume":"10","author":"Martinon","year":"2002","journal-title":"Mol. Cell"},{"issue":"1","key":"10.1016\/j.neuropharm.2024.110217_bib222","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1124\/mol.110.068064","article-title":"TAK-242 (resatorvid), a small-molecule inhibitor of Toll-like receptor (TLR) 4 signaling, binds selectively to TLR4 and interferes with interactions between TLR4 and its adaptor molecules","volume":"79","author":"Matsunaga","year":"2011","journal-title":"Mol. Pharmacol."},{"issue":"6378","key":"10.1016\/j.neuropharm.2024.110217_bib223","doi-asserted-by":"crossref","DOI":"10.1126\/science.aao6047","article-title":"BAK\/BAX macropores facilitate mitochondrial herniation and mtDNA efflux during apoptosis","volume":"359","author":"Mcarthur","year":"2018","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.neuropharm.2024.110217_bib224","doi-asserted-by":"crossref","first-page":"246","DOI":"10.2174\/156652411795243450","article-title":"The Role of immune and inflammatory mechanisms in ALS","volume":"11","author":"Mccombe","year":"2011","journal-title":"Curr. Mol. Med."},{"issue":"6","key":"10.1016\/j.neuropharm.2024.110217_bib225","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1358\/dot.2009.45.6.1378935","article-title":"Rilonacept in the treatment of chronic inflammatory disorders","volume":"45","author":"Mcdermott","year":"2009","journal-title":"Drugs Today"},{"key":"10.1016\/j.neuropharm.2024.110217_bib226","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ymeth.2018.01.016","article-title":"Advanced flow cytometry techniques for clinical detection","volume":"134\u2013135","author":"Mcfarlin","year":"2018","journal-title":"Methods"},{"issue":"29","key":"10.1016\/j.neuropharm.2024.110217_bib227","doi-asserted-by":"crossref","first-page":"13046","DOI":"10.1073\/pnas.1002396107","article-title":"Mutant superoxide dismutase 1-induced IL-1beta accelerates ALS pathogenesis","volume":"107","author":"Meissner","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"3","key":"10.1016\/j.neuropharm.2024.110217_bib228","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/cr.2018.16","article-title":"UPR(mt) regulation and output: a stress response mediated by mitochondrial-nuclear communication","volume":"28","author":"Melber","year":"2018","journal-title":"Cell Res."},{"key":"10.1016\/j.neuropharm.2024.110217_bib229","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.tox.2017.07.019","article-title":"Mitochondrial fusion, fission, and mitochondrial toxicity","volume":"391","author":"Meyer","year":"2017","journal-title":"Toxicology"},{"key":"10.1016\/j.neuropharm.2024.110217_bib230","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/978-94-007-5416-4_16","article-title":"Parkinson's disease","volume":"65","author":"Mhyre","year":"2012","journal-title":"Subcell. Biochem."},{"issue":"6","key":"10.1016\/j.neuropharm.2024.110217_bib231","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.cytogfr.2006.09.009","article-title":"Formyl peptide receptors: a promiscuous subfamily of G protein-coupled receptors controlling immune responses","volume":"17","author":"Migeotte","year":"2006","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.neuropharm.2024.110217_bib232","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/2183026","article-title":"ROS-mediated NLRP3 inflammasome activation in brain, heart, kidney, and testis ischemia\/reperfusion injury","volume":"2016","author":"Minutoli","year":"2016","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"3","key":"10.1016\/j.neuropharm.2024.110217_bib233","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s12079-019-00507-9","article-title":"Mitochondria: the indispensable players in innate immunity and guardians of the inflammatory response","volume":"13","author":"Mohanty","year":"2019","journal-title":"J Cell Commun Signal"},{"key":"10.1016\/j.neuropharm.2024.110217_bib234","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/6978936","article-title":"The role of toll-like receptor 4 in infectious and noninfectious inflammation","volume":"2016","author":"Molteni","year":"2016","journal-title":"Mediat. Inflamm."},{"issue":"4","key":"10.1016\/j.neuropharm.2024.110217_bib235","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.3233\/JAD-141002","article-title":"Cardiolipin profile changes are associated to the early synaptic mitochondrial dysfunction in Alzheimer's disease","volume":"43","author":"Monteiro-Cardoso","year":"2015","journal-title":"J Alzheimers Dis"},{"issue":"17","key":"10.1016\/j.neuropharm.2024.110217_bib236","doi-asserted-by":"crossref","first-page":"3799","DOI":"10.1097\/00001756-200011270-00041","article-title":"Immunohistochemical localization of the P2Y1 purinergic receptor in Alzheimer's disease","volume":"11","author":"Moore","year":"2000","journal-title":"Neuroreport"},{"issue":"4","key":"10.1016\/j.neuropharm.2024.110217_bib237","doi-asserted-by":"crossref","first-page":"169","DOI":"10.4103\/2319-4170.127803","article-title":"The role of P2X7 receptor in infectious inflammatory diseases and the influence of ectonucleotidases","volume":"37","author":"Morandini","year":"2014","journal-title":"Biomed. J."},{"issue":"1","key":"10.1016\/j.neuropharm.2024.110217_bib238","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1093\/bmb\/ldw026","article-title":"Pathogenesis of amyotrophic lateral sclerosis","volume":"119","author":"Morgan","year":"2016","journal-title":"Br. Med. Bull."},{"issue":"10423","key":"10.1016\/j.neuropharm.2024.110217_bib239","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0140-6736(23)01478-2","article-title":"The pathogenesis of Parkinson's disease","volume":"403","author":"Morris","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.neuropharm.2024.110217_bib240","doi-asserted-by":"crossref","DOI":"10.1038\/srep45032","article-title":"Signalling mechanisms mediating Zn(2+)-induced TRPM2 channel activation and cell death in microglial cells","volume":"7","author":"Mortadza","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuropharm.2024.110217_bib241","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms11932","article-title":"Activation of STING requires palmitoylation at the Golgi","volume":"7","author":"Mukai","year":"2016","journal-title":"Nat. Commun."},{"issue":"6","key":"10.1016\/j.neuropharm.2024.110217_bib242","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/d41573-019-00086-9","article-title":"NLRP3 inhibitors stoke anti-inflammatory ambitions","volume":"18","author":"Mullard","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"issue":"3\u20134","key":"10.1016\/j.neuropharm.2024.110217_bib243","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1007\/s10495-021-01663-3","article-title":"Release mechanisms of major DAMPs","volume":"26","author":"Murao","year":"2021","journal-title":"Apoptosis"},{"issue":"7","key":"10.1016\/j.neuropharm.2024.110217_bib244","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.4049\/jimmunol.1601400","article-title":"TLR4: the winding road to the discovery of the LPS receptor","volume":"197","author":"Murdock","year":"2016","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.neuropharm.2024.110217_bib245","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.bbamcr.2011.10.003","article-title":"IRAK-1-mediated negative regulation of Toll-like receptor signaling through proteasome-dependent downregulation of TRAF6","volume":"1823","author":"Muroi","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"issue":"11","key":"10.1016\/j.neuropharm.2024.110217_bib246","doi-asserted-by":"crossref","first-page":"7637","DOI":"10.1016\/S0021-9258(18)42563-X","article-title":"A structural homologue of the N-formyl peptide receptor. Characterization and chromosome mapping of a peptide chemoattractant receptor family","volume":"267","author":"Murphy","year":"1992","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.neuropharm.2024.110217_bib247","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/ni.1980","article-title":"Autophagy proteins regulate innate immune responses by inhibiting the release of mitochondrial DNA mediated by the NALP3 inflammasome","volume":"12","author":"Nakahira","year":"2011","journal-title":"Nat. Immunol."},{"issue":"17","key":"10.1016\/j.neuropharm.2024.110217_bib248","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1089\/ars.2015.6407","article-title":"The roles of mitochondrial damage-associated molecular patterns in diseases","volume":"23","author":"Nakahira","year":"2015","journal-title":"Antioxidants Redox Signal."},{"issue":"3","key":"10.1016\/j.neuropharm.2024.110217_bib249","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s11064-010-0347-4","article-title":"TRPM2 cation channels, oxidative stress and neurological diseases: where are we now?","volume":"36","author":"Naz\u0131ro\u011flu","year":"2011","journal-title":"Neurochem. Res."},{"issue":"5726","key":"10.1016\/j.neuropharm.2024.110217_bib250","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1126\/science.1110647","article-title":"Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo","volume":"308","author":"Nimmerjahn","year":"2005","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.neuropharm.2024.110217_bib251","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1152\/physrev.00015.2002","article-title":"Molecular physiology of P2X receptors","volume":"82","author":"North","year":"2002","journal-title":"Physiol. Rev."},{"issue":"3","key":"10.1016\/j.neuropharm.2024.110217_bib252","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1080\/10799893.2020.1806321","article-title":"Effects of homocysteine and memantine on oxidative stress related TRP cation channels in in-vitro model of Alzheimer's disease","volume":"41","author":"\u00d6vey","year":"2021","journal-title":"J. Recept. Signal Transduct. Res."},{"issue":"7549","key":"10.1016\/j.neuropharm.2024.110217_bib253","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1038\/nature14138","article-title":"Structural basis of CpG and inhibitory DNA recognition by Toll-like receptor 9","volume":"520","author":"Ohto","year":"2015","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.neuropharm.2024.110217_bib254","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/s12974-021-02126-x","article-title":"Inhibition of TLR4 signaling protects mice from sensory and motor dysfunction in an animal model of autoimmune peripheral neuropathy","volume":"18","author":"Oladiran","year":"2021","journal-title":"J. Neuroinflammation"},{"issue":"1","key":"10.1016\/j.neuropharm.2024.110217_bib255","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/nrm2299","article-title":"Heterotrimeric G protein activation by G-protein-coupled receptors","volume":"9","author":"Oldham","year":"2008","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"1","key":"10.1016\/j.neuropharm.2024.110217_bib256","doi-asserted-by":"crossref","first-page":"51","DOI":"10.2174\/1389450119666180821105544","article-title":"Toll-like receptor 4 and heat-shock protein 70: is it a new target pathway for diabetic vasculopathies?","volume":"20","author":"De Oliveira","year":"2019","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.neuropharm.2024.110217_bib257","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.624919","article-title":"Unraveling the link between mitochondrial dynamics and neuroinflammation","volume":"12","author":"De Oliveira","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.neuropharm.2024.110217_bib258","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2020.567430","article-title":"P2X7 receptor upregulation in Huntington's disease brains","volume":"13","author":"Oll\u00e0","year":"2020","journal-title":"Front. Mol. Neurosci."},{"issue":"11","key":"10.1016\/j.neuropharm.2024.110217_bib259","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1007\/s11094-022-02548-8","article-title":"Bioavailability and safety of dihydroquercetin","volume":"55","author":"Orlova","year":"2022","journal-title":"Pharm. Chem. J."},{"issue":"6","key":"10.1016\/j.neuropharm.2024.110217_bib260","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.beem.2012.05.003","article-title":"Cellular and molecular mechanisms of mitochondrial function","volume":"26","author":"Osellame","year":"2012","journal-title":"Best Pract. Res. Clin. Endocrinol. Metabol."},{"issue":"6","key":"10.1016\/j.neuropharm.2024.110217_bib261","doi-asserted-by":"crossref","first-page":"431","DOI":"10.2217\/nmt-2021-0042","article-title":"MN-166 (ibudilast) in amyotrophic lateral sclerosis in a Phase IIb\/III study: COMBAT-ALS study design","volume":"11","author":"Oskarsson","year":"2021","journal-title":"Neurodegener. Dis. Manag."},{"key":"10.1016\/j.neuropharm.2024.110217_bib262","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1044662","article-title":"MyD88-dependent signaling drives toll-like receptor-induced trained immunity in macrophages","volume":"13","author":"Owen","year":"2022","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.neuropharm.2024.110217_bib263","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/j.clinthera.2016.02.028","article-title":"Key role of DAMP in inflammation, cancer, and tissue repair","volume":"38","author":"Pandolfi","year":"2016","journal-title":"Clin. Therapeut."},{"issue":"2","key":"10.1016\/j.neuropharm.2024.110217_bib264","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s00424-011-1039-x","article-title":"Differential pathways for calcium influx activated by concanavalin A and CD3 stimulation in Jurkat T cells","volume":"463","author":"Pang","year":"2012","journal-title":"Pfl\u00fcgers Archiv"},{"issue":"7242","key":"10.1016\/j.neuropharm.2024.110217_bib265","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1038\/nature07830","article-title":"The structural basis of lipopolysaccharide recognition by the TLR4-MD-2 complex","volume":"458","author":"Park","year":"2009","journal-title":"Nature"},{"issue":"52","key":"10.1016\/j.neuropharm.2024.110217_bib266","doi-asserted-by":"crossref","first-page":"40762","DOI":"10.1074\/jbc.M110.169276","article-title":"The 1.5 \u00c5 crystal structure of human receptor for advanced glycation endproducts (RAGE) ectodomains reveals unique features determining ligand binding","volume":"285","author":"Park","year":"2010","journal-title":"J. Biol. Chem."},{"issue":"7531","key":"10.1016\/j.neuropharm.2024.110217_bib267","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1038\/nature13818","article-title":"Mitochondrial UPR-regulated innate immunity provides resistance to pathogen infection","volume":"516","author":"Pellegrino","year":"2014","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.neuropharm.2024.110217_bib268","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1136\/gutjnl-2018-316844","article-title":"Role of TLR4 in the gut-brain axis in Parkinson's disease: a translational study from men to mice","volume":"68","author":"Perez-Pardo","year":"2019","journal-title":"Gut"},{"issue":"5","key":"10.1016\/j.neuropharm.2024.110217_bib269","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1007\/s00281-013-0382-8","article-title":"Microglia and macrophages of the central nervous system: the contribution of microglia priming and systemic inflammation to chronic neurodegeneration","volume":"35","author":"Perry","year":"2013","journal-title":"Semin. Immunopathol."},{"key":"10.1016\/j.neuropharm.2024.110217_bib270","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.mito.2014.05.001","article-title":"Reduction in mitochondrial DNA copy number in peripheral leukocytes after onset of Huntington's disease","volume":"17","author":"Petersen","year":"2014","journal-title":"Mitochondrion"},{"issue":"5","key":"10.1016\/j.neuropharm.2024.110217_bib271","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.bbagen.2011.08.007","article-title":"Overexpression of TFAM, NRF-1 and myr-AKT protects the MPP(+)-induced mitochondrial dysfunctions in neuronal cells","volume":"1820","author":"Piao","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"issue":"11","key":"10.1016\/j.neuropharm.2024.110217_bib272","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1016\/j.cmet.2022.10.008","article-title":"Mitochondrial signal transduction","volume":"34","author":"Picard","year":"2022","journal-title":"Cell Metabol."},{"issue":"3","key":"10.1016\/j.neuropharm.2024.110217_bib273","doi-asserted-by":"crossref","DOI":"10.3390\/cells10030537","article-title":"Cell death and inflammation: the role of mitochondria in health and disease","volume":"10","author":"Picca","year":"2021","journal-title":"Cells"},{"issue":"2","key":"10.1016\/j.neuropharm.2024.110217_bib274","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.neuron.2014.12.007","article-title":"The roles of PINK1, parkin, and mitochondrial fidelity in Parkinson's disease","volume":"85","author":"Pickrell","year":"2015","journal-title":"Neuron"},{"issue":"11","key":"10.1016\/j.neuropharm.2024.110217_bib275","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/j.tcb.2020.09.004","article-title":"Cardiolipin in immune signaling and cell death","volume":"30","author":"Pizzuto","year":"2020","journal-title":"Trends Cell Biol."},{"issue":"5","key":"10.1016\/j.neuropharm.2024.110217_bib276","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1002\/ana.23955","article-title":"Low cerebrospinal fluid concentration of mitochondrial DNA in preclinical Alzheimer disease","volume":"74","author":"Podlesniy","year":"2013","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neuropharm.2024.110217_bib277","article-title":"Parkinson disease","volume":"3","author":"Poewe","year":"2017","journal-title":"Nat. Rev. Dis. Prim."},{"issue":"2","key":"10.1016\/j.neuropharm.2024.110217_bib278","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1038\/s41590-019-0569-9","article-title":"Homeostatic regulation of STING protein at the resting state by stabilizer TOLLIP","volume":"21","author":"Pokatayev","year":"2020","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.neuropharm.2024.110217_bib279","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.neurobiolaging.2015.10.033","article-title":"Reduced mitochondrial DNA copy number is a biomarker of Parkinson's disease","volume":"38","author":"Pyle","year":"2016","journal-title":"Neurobiol. Aging"},{"issue":"6","key":"10.1016\/j.neuropharm.2024.110217_bib280","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.molcel.2023.02.012","article-title":"Determinants and outcomes of mitochondrial dynamics","volume":"83","author":"Quintana-Cabrera","year":"2023","journal-title":"Mol. Cell"},{"issue":"16","key":"10.1016\/j.neuropharm.2024.110217_bib281","first-page":"1565","article-title":"TREM2 and neurodegenerative disease","volume":"369","author":"Rajagopalan","year":"2013","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.neuropharm.2024.110217_bib282","first-page":"413","article-title":"Receptors for purines and pyrimidines","volume":"50","author":"Ralevic","year":"1998","journal-title":"Pharmacol. Rev."},{"issue":"4","key":"10.1016\/j.neuropharm.2024.110217_bib283","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1172\/JCI58644","article-title":"Innate immunity in the central nervous system","volume":"122","author":"Ransohoff","year":"2012","journal-title":"J. Clin. Invest."},{"issue":"6","key":"10.1016\/j.neuropharm.2024.110217_bib284","first-page":"1328","article-title":"Mitochondrial peptides are potent immune activators that activate human neutrophils via FPR-1","volume":"68","author":"Raoof","year":"2010","journal-title":"J. Trauma"},{"issue":"4","key":"10.1016\/j.neuropharm.2024.110217_bib285","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.cell.2016.03.046","article-title":"Inflammasome complexes: emerging mechanisms and effector functions","volume":"165","author":"Rathinam","year":"2016","journal-title":"Cell"},{"issue":"15","key":"10.1016\/j.neuropharm.2024.110217_bib286","doi-asserted-by":"crossref","first-page":"5981","DOI":"10.1073\/pnas.1218778110","article-title":"The mitochondrial unfolded protein response activator ATFS-1 protects cells from inhibition of the mevalonate pathway","volume":"110","author":"Rauthan","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2024.110217_bib287","doi-asserted-by":"crossref","DOI":"10.1016\/j.neubiorev.2022.104961","article-title":"Mitochondrial dysfunctions, oxidative stress and neuroinflammation as therapeutic targets for neurodegenerative diseases: an update on current advances and impediments","volume":"144","author":"Rehman","year":"2023","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"5","key":"10.1016\/j.neuropharm.2024.110217_bib288","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1038\/nbt.3835","article-title":"Induction of functional dopamine neurons from human astrocytes in vitro and mouse astrocytes in a Parkinson's disease model","volume":"35","author":"Rivetti Di Val Cervo","year":"2017","journal-title":"Nat. Biotechnol."},{"issue":"1","key":"10.1016\/j.neuropharm.2024.110217_bib289","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1093\/cvr\/cvu112","article-title":"TNF-\u03b1-mediated caspase-8 activation induces ROS production and TRPM2 activation in adult ventricular myocytes","volume":"103","author":"Roberge","year":"2014","journal-title":"Cardiovasc. Res."},{"issue":"3","key":"10.1016\/j.neuropharm.2024.110217_bib290","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1002\/glia.22444","article-title":"Extracellular aggregated Cu\/Zn superoxide dismutase activates microglia to give a cytotoxic phenotype","volume":"61","author":"Roberts","year":"2013","journal-title":"Glia"},{"issue":"6","key":"10.1016\/j.neuropharm.2024.110217_bib291","doi-asserted-by":"crossref","first-page":"195","DOI":"10.15698\/cst2019.06.190","article-title":"The sensing of mitochondrial DAMPs by non-immune cells","volume":"3","author":"Rodriguez-Nuevo","year":"2019","journal-title":"Cell Stress"},{"issue":"4","key":"10.1016\/j.neuropharm.2024.110217_bib292","doi-asserted-by":"crossref","first-page":"e27","DOI":"10.4110\/in.2018.18.e27","article-title":"Damage-associated molecular patterns in inflammatory diseases","volume":"18","author":"Roh","year":"2018","journal-title":"Immune Netw"},{"issue":"4","key":"10.1016\/j.neuropharm.2024.110217_bib293","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.immuni.2021.02.004","article-title":"Post-injury immunosuppression and secondary infections are caused by an AIM2 inflammasome-driven signaling cascade","volume":"54","author":"Roth","year":"2021","journal-title":"Immunity"},{"issue":"3","key":"10.1016\/j.neuropharm.2024.110217_bib294","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s00281-023-00993-5","article-title":"The role of circulating cell-free DNA as an inflammatory mediator after stroke","volume":"45","author":"Roth","year":"2023","journal-title":"Semin. Immunopathol."},{"key":"10.1016\/j.neuropharm.2024.110217_bib295","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.intimp.2016.08.026","article-title":"Potential therapeutic targets for inflammation in toll-like receptor 4 (TLR4)-mediated signaling pathways","volume":"40","author":"Roy","year":"2016","journal-title":"Int. Immunopharm."},{"issue":"0 1","key":"10.1016\/j.neuropharm.2024.110217_bib296","first-page":"S87","article-title":"Neurovascular defects and faulty amyloid-\u03b2 vascular clearance in Alzheimer's disease","volume":"33","author":"Sagare","year":"2013","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.neuropharm.2024.110217_bib297","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/978-1-4939-9658-2_2","article-title":"Morphology of microglia across contexts of health and disease","volume":"2034","author":"Savage","year":"2019","journal-title":"Methods Mol. Biol."},{"issue":"10284","key":"10.1016\/j.neuropharm.2024.110217_bib298","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1016\/S0140-6736(20)32205-4","article-title":"Alzheimer's disease","volume":"397","author":"Scheltens","year":"2021","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.neuropharm.2024.110217_bib299","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1002\/ana.10176","article-title":"Deficiency of tetralinoleoyl-cardiolipin in Barth syndrome","volume":"51","author":"Schlame","year":"2002","journal-title":"Ann. Neurol."},{"issue":"0","key":"10.1016\/j.neuropharm.2024.110217_bib300","first-page":"137","article-title":"Ibudilast: a non-selective phosphodiesterase inhibitor in brain disorders","volume":"71","author":"Schwenkgrub","year":"2017","journal-title":"Postepy Hig. Med. Dosw."},{"issue":"4","key":"10.1016\/j.neuropharm.2024.110217_bib301","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1073\/pnas.0906039107","article-title":"A plasma signature of human mitochondrial disease revealed through metabolic profiling of spent media from cultured muscle cells","volume":"107","author":"Shaham","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"9","key":"10.1016\/j.neuropharm.2024.110217_bib302","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1002\/jnr.21644","article-title":"Advanced glycation end products induce in vitro cross-linking of alpha-synuclein and accelerate the process of intracellular inclusion body formation","volume":"86","author":"Shaikh","year":"2008","journal-title":"J. Neurosci. Res."},{"issue":"9\u201310","key":"10.1016\/j.neuropharm.2024.110217_bib303","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.imbio.2008.07.008","article-title":"From expression to signaling: roles of TREM-1 and TREM-2 in innate immunity and bacterial infection","volume":"213","author":"Sharif","year":"2008","journal-title":"Immunobiology"},{"issue":"27","key":"10.1016\/j.neuropharm.2024.110217_bib304","doi-asserted-by":"crossref","first-page":"15989","DOI":"10.1073\/pnas.2002144117","article-title":"Cyclic GMP-AMP synthase promotes the inflammatory and autophagy responses in Huntington disease","volume":"117","author":"Sharma","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"4","key":"10.1016\/j.neuropharm.2024.110217_bib305","doi-asserted-by":"crossref","first-page":"330","DOI":"10.2478\/jtim-2022-0019","article-title":"Mitochondrial damage-associated molecular patterns in chronic obstructive pulmonary disease: pathogenetic mechanism and therapeutic target","volume":"11","author":"Shen","year":"2023","journal-title":"J Transl Int Med"},{"key":"10.1016\/j.neuropharm.2024.110217_bib306","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.107358","article-title":"NLRP3 inflammasome inhibitor INF39 attenuated NLRP3 assembly in macrophages","volume":"92","author":"Shi","year":"2021","journal-title":"Int. Immunopharm."},{"key":"10.1016\/j.neuropharm.2024.110217_bib307","doi-asserted-by":"crossref","DOI":"10.1177\/10738584241254118","article-title":"Microglia, Trem2, and neurodegeneration","author":"Shi","year":"2024","journal-title":"Neuroscientist"},{"issue":"3","key":"10.1016\/j.neuropharm.2024.110217_bib308","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1111\/j.1471-4159.2010.06809.x","article-title":"P2X7 receptor activation induces CXCL2 production in microglia through NFAT and PKC\/MAPK pathways","volume":"114","author":"Shiratori","year":"2010","journal-title":"J. Neurochem."},{"issue":"2","key":"10.1016\/j.neuropharm.2024.110217_bib309","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/nrm.2017.110","article-title":"The mitochondrial UPR: mechanisms, physiological functions and implications in ageing","volume":"19","author":"Shpilka","year":"2018","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"1","key":"10.1016\/j.neuropharm.2024.110217_bib310","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1021\/acsmedchemlett.8b00466","article-title":"Discovery of a novel cGAMP competitive ligand of the inactive form of STING","volume":"10","author":"Siu","year":"2019","journal-title":"ACS Med. Chem. Lett."},{"issue":"7722","key":"10.1016\/j.neuropharm.2024.110217_bib311","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1038\/s41586-018-0448-9","article-title":"Parkin and PINK1 mitigate STING-induced inflammation","volume":"561","author":"Sliter","year":"2018","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.neuropharm.2024.110217_bib312","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s00401-009-0619-8","article-title":"Astrocytes: biology and pathology","volume":"119","author":"Sofroniew","year":"2010","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.neuropharm.2024.110217_bib313","doi-asserted-by":"crossref","DOI":"10.1155\/2011\/792639","article-title":"Mitogen-activated protein kinases and reactive oxygen species: how can ROS activate MAPK pathways?","volume":"2011","author":"Son","year":"2011","journal-title":"J Signal Transduct"},{"issue":"4","key":"10.1016\/j.neuropharm.2024.110217_bib314","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1104\/pp.105.073072","article-title":"Extracellular ATP induces the accumulation of superoxide via NADPH oxidases in Arabidopsis","volume":"140","author":"Song","year":"2006","journal-title":"Plant Physiol."},{"key":"10.1016\/j.neuropharm.2024.110217_bib315","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/1742-2094-8-92","article-title":"TLR4 mutation reduces microglial activation, increases A\u03b2 deposits and exacerbates cognitive deficits in a mouse model of Alzheimer's disease","volume":"8","author":"Song","year":"2011","journal-title":"J. Neuroinflammation"},{"issue":"7","key":"10.1016\/j.neuropharm.2024.110217_bib316","doi-asserted-by":"crossref","first-page":"4381","DOI":"10.1007\/s12035-023-03841-7","article-title":"The protective mechanism of TFAM on mitochondrial DNA and its role in neurodegenerative diseases","volume":"61","author":"Song","year":"2023","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.neuropharm.2024.110217_bib317","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1479-5876-7-17","article-title":"RAGE (Receptor for Advanced Glycation Endproducts), RAGE ligands, and their role in cancer and inflammation","volume":"7","author":"Sparvero","year":"2009","journal-title":"J. Transl. Med."},{"issue":"5870","key":"10.1016\/j.neuropharm.2024.110217_bib318","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1126\/science.1154584","article-title":"TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis","volume":"319","author":"Sreedharan","year":"2008","journal-title":"Science"},{"issue":"23","key":"10.1016\/j.neuropharm.2024.110217_bib319","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1056\/NEJMc2314334","article-title":"Homozygosity for R47H in TREM2 and the risk of Alzheimer's disease","volume":"390","author":"Stefansson","year":"2024","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.neuropharm.2024.110217_bib320","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1002\/eji.201747338","article-title":"Suppressive oligodeoxynucleotides containing TTAGGG motifs inhibit cGAS activation in human monocytes","volume":"48","author":"Steinhagen","year":"2018","journal-title":"Eur. J. Immunol."},{"issue":"6","key":"10.1016\/j.neuropharm.2024.110217_bib321","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1007\/s10753-007-9040-4","article-title":"Boc-MLF and Boc-FLFLF are antagonists that preferentially inhibit activity triggered through the formyl peptide receptor","volume":"30","author":"Stenfeldt","year":"2007","journal-title":"Inflammation"},{"issue":"11","key":"10.1016\/j.neuropharm.2024.110217_bib322","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.2217\/epi-2018-0072","article-title":"Mitochondrial DNA copy number and D-loop region methylation in carriers of amyotrophic lateral sclerosis gene mutations","volume":"10","author":"Stoccoro","year":"2018","journal-title":"Epigenomics"},{"key":"10.1016\/j.neuropharm.2024.110217_bib323","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2021.101318","article-title":"Therapy for Alzheimer's disease: missing targets and functional markers?","volume":"68","author":"Stoiljkovic","year":"2021","journal-title":"Ageing Res. Rev."},{"issue":"6121","key":"10.1016\/j.neuropharm.2024.110217_bib324","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1126\/science.1232458","article-title":"Cyclic GMP-AMP synthase is a cytosolic DNA sensor that activates the type I interferon pathway","volume":"339","author":"Sun","year":"2013","journal-title":"Science"},{"issue":"12","key":"10.1016\/j.neuropharm.2024.110217_bib325","doi-asserted-by":"crossref","first-page":"5546","DOI":"10.1080\/21645515.2021.1964316","article-title":"Using PAMPs and DAMPs as adjuvants in cancer vaccines","volume":"17","author":"Sun","year":"2021","journal-title":"Hum. Vaccines Immunother."},{"issue":"3","key":"10.1016\/j.neuropharm.2024.110217_bib326","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1097\/01.CCM.0000155991.88802.4D","article-title":"Persistent elevation of high mobility group box-1 protein (HMGB1) in patients with severe sepsis and septic shock","volume":"33","author":"Sund\u00e9n-Cullberg","year":"2005","journal-title":"Crit. Care Med."},{"issue":"1","key":"10.1016\/j.neuropharm.2024.110217_bib327","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/1750-1326-6-32","article-title":"PGC-1alpha downstream transcription factors NRF-1 and TFAM are genetic modifiers of Huntington disease","volume":"6","author":"Taherzadeh-Fard","year":"2011","journal-title":"Mol. Neurodegener."},{"issue":"1","key":"10.1016\/j.neuropharm.2024.110217_bib328","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.smim.2003.10.003","article-title":"TLR signaling pathways","volume":"16","author":"Takeda","year":"2004","journal-title":"Semin. Immunol."},{"issue":"7444","key":"10.1016\/j.neuropharm.2024.110217_bib329","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1038\/nature11986","article-title":"Succinate is an inflammatory signal that induces IL-1\u03b2 through HIF-1\u03b1","volume":"496","author":"Tannahill","year":"2013","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.neuropharm.2024.110217_bib330","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a006296","article-title":"The genetics of Alzheimer disease","volume":"2","author":"Tanzi","year":"2012","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"7628","key":"10.1016\/j.neuropharm.2024.110217_bib331","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/nature20413","article-title":"Decoding ALS: from genes to mechanism","volume":"539","author":"Taylor","year":"2016","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.neuropharm.2024.110217_bib332","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1016\/j.neuroscience.2008.07.031","article-title":"Systemic infection and inflammation in acute CNS injury and chronic neurodegeneration: underlying mechanisms","volume":"158","author":"Teeling","year":"2009","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2024.110217_bib333","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2021.617036","article-title":"P2X(7) receptors in neurodegeneration: potential therapeutic applications from basic to clinical approaches","volume":"15","author":"Territo","year":"2021","journal-title":"Front. Cell. Neurosci."},{"issue":"Pt A","key":"10.1016\/j.neuropharm.2024.110217_bib334","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.arr.2014.11.003","article-title":"DAMPs and neurodegeneration","volume":"24","author":"Thundyil","year":"2015","journal-title":"Ageing Res. Rev."},{"issue":"3","key":"10.1016\/j.neuropharm.2024.110217_bib335","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1042\/EBC20170104","article-title":"Mitochondrial dynamics: overview of molecular mechanisms","volume":"62","author":"Tilokani","year":"2018","journal-title":"Essays Biochem."},{"issue":"Pt 1","key":"10.1016\/j.neuropharm.2024.110217_bib336","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1093\/brain\/awp282","article-title":"Brain alpha-synuclein accumulation in multiple system atrophy, Parkinson's disease and progressive supranuclear palsy: a comparative investigation","volume":"133","author":"Tong","year":"2010","journal-title":"Brain"},{"issue":"4","key":"10.1016\/j.neuropharm.2024.110217_bib337","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.yjmcc.2010.11.003","article-title":"Therapeutic targeting of innate immunity in the failing heart","volume":"51","author":"Topkara","year":"2011","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"9","key":"10.1016\/j.neuropharm.2024.110217_bib338","doi-asserted-by":"crossref","first-page":"3806","DOI":"10.1038\/s41380-023-02189-7","article-title":"Activation of cell-free mtDNA-TLR9 signaling mediates chronic stress-induced social behavior deficits","volume":"28","author":"Tripathi","year":"2023","journal-title":"Mol. Psychiatr."},{"issue":"14","key":"10.1016\/j.neuropharm.2024.110217_bib339","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1002\/(SICI)1097-0061(199910)15:14<1555::AID-YEA479>3.0.CO;2-Z","article-title":"Lipid composition of subcellular membranes of an FY1679-derived haploid yeast wild-type strain grown on different carbon sources","volume":"15","author":"Tuller","year":"1999","journal-title":"Yeast"},{"issue":"5","key":"10.1016\/j.neuropharm.2024.110217_bib340","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1038\/aps.2017.194","article-title":"The role of TRPM2 channels in neurons, glial cells and the blood-brain barrier in cerebral ischemia and hypoxia","volume":"39","author":"Turlova","year":"2018","journal-title":"Acta Pharmacol. Sin."},{"issue":"5","key":"10.1016\/j.neuropharm.2024.110217_bib341","doi-asserted-by":"crossref","first-page":"681","DOI":"10.3109\/10715762.2015.1005085","article-title":"LC\/MS analysis of cardiolipins in substantia nigra and plasma of rotenone-treated rats: implication for mitochondrial dysfunction in Parkinson's disease","volume":"49","author":"Tyurina","year":"2015","journal-title":"Free Radic. Res."},{"issue":"4","key":"10.1016\/j.neuropharm.2024.110217_bib342","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1080\/10799893.2020.1742741","article-title":"Curcumin analogs as the inhibitors of TLR4 pathway in inflammation and their drug like potentialities: a computer-based study","volume":"40","author":"Ullah","year":"2020","journal-title":"J. Recept. Signal Transduct. Res."},{"key":"10.1016\/j.neuropharm.2024.110217_bib343","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/978-94-007-7423-0_3","article-title":"Structure and dynamics of G-protein coupled receptors","volume":"796","author":"Vaidehi","year":"2014","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.neuropharm.2024.110217_bib344","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.mito.2016.12.003","article-title":"Increased levels of cell-free mitochondrial DNA in the cerebrospinal fluid of patients with multiple sclerosis","volume":"34","author":"Varhaug","year":"2017","journal-title":"Mitochondrion"},{"issue":"3","key":"10.1016\/j.neuropharm.2024.110217_bib345","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/S0006-291X(03)00622-3","article-title":"Mammalian mitochondrial IAP binding proteins","volume":"304","author":"Vaux","year":"2003","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.neuropharm.2024.110217_bib346","doi-asserted-by":"crossref","first-page":"422","DOI":"10.3389\/fimmu.2015.00422","article-title":"DAMPs from cell death to new life","volume":"6","author":"Venereau","year":"2015","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.neuropharm.2024.110217_bib347","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1038\/s41467-017-00833-9","article-title":"Small molecule inhibition of cGAS reduces interferon expression in primary macrophages from autoimmune mice","volume":"8","author":"Vincent","year":"2017","journal-title":"Nat. Commun."},{"issue":"4","key":"10.1016\/j.neuropharm.2024.110217_bib348","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1073\/pnas.91.4.1309","article-title":"Activation of the human mitochondrial transcription factor A gene by nuclear respiratory factors: a potential regulatory link between nuclear and mitochondrial gene expression in organelle biogenesis","volume":"91","author":"Virbasius","year":"1994","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2024.110217_bib349","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.neuropharm.2015.10.026","article-title":"Purinergic contribution to amyotrophic lateral sclerosis","volume":"104","author":"Volont\u00e9","year":"2016","journal-title":"Neuropharmacology"},{"issue":"6","key":"10.1016\/j.neuropharm.2024.110217_bib350","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1038\/s44318-024-00044-1","article-title":"Mitochondrial outer membrane integrity regulates a ubiquitin-dependent and NF-\u03baB-mediated inflammatory response","volume":"43","author":"Vringer","year":"2024","journal-title":"EMBO J."},{"issue":"1","key":"10.1016\/j.neuropharm.2024.110217_bib351","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/nrneph.2015.175","article-title":"Innate immunity in diabetes and diabetic nephropathy","volume":"12","author":"Wada","year":"2016","journal-title":"Nat. Rev. Nephrol."},{"issue":"6","key":"10.1016\/j.neuropharm.2024.110217_bib352","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1159\/000110455","article-title":"Role of the toll-like receptor 4 in neuroinflammation in Alzheimer's disease","volume":"20","author":"Walter","year":"2007","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.neuropharm.2024.110217_bib353","doi-asserted-by":"crossref","DOI":"10.1016\/j.mam.2020.100889","article-title":"The NLRP3 inflammasome: mechanism of action, role in disease and therapies","volume":"76","author":"Wang","year":"2020","journal-title":"Mol. Aspect. Med."},{"issue":"6844","key":"10.1016\/j.neuropharm.2024.110217_bib354","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/35085597","article-title":"TAK1 is a ubiquitin-dependent kinase of MKK and IKK","volume":"412","author":"Wang","year":"2001","journal-title":"Nature"},{"issue":"33","key":"10.1016\/j.neuropharm.2024.110217_bib355","doi-asserted-by":"crossref","first-page":"29874","DOI":"10.1074\/jbc.M203915200","article-title":"PYPAF7, a novel PYRIN-containing Apaf1-like protein that regulates activation of NF-kappa B and caspase-1-dependent cytokine processing","volume":"277","author":"Wang","year":"2002","journal-title":"J. Biol. Chem."},{"issue":"11","key":"10.1016\/j.neuropharm.2024.110217_bib356","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.4155\/fmc-2017-0322","article-title":"Suramin potently inhibits cGAMP synthase, cGAS, in THP1 cells to modulate IFN-\u03b2 levels","volume":"10","author":"Wang","year":"2018","journal-title":"Future Med. Chem."},{"issue":"2","key":"10.1016\/j.neuropharm.2024.110217_bib357","doi-asserted-by":"crossref","DOI":"10.1002\/dmrr.3733","article-title":"Mitochondrial damage-associated molecular patterns: a new insight into metabolic inflammation in type 2 diabetes mellitus","volume":"40","author":"Wang","year":"2024","journal-title":"Diabetes Metab Res Rev"},{"issue":"1","key":"10.1016\/j.neuropharm.2024.110217_bib358","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1523\/JNEUROSCI.3561-14.2015","article-title":"Stress induces the danger-associated molecular pattern HMGB-1 in the hippocampus of male Sprague Dawley rats: a priming stimulus of microglia and the NLRP3 inflammasome","volume":"35","author":"Weber","year":"2015","journal-title":"J. Neurosci."},{"issue":"1","key":"10.1016\/j.neuropharm.2024.110217_bib359","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-55863-8","article-title":"Targeting of cell-free DNA by DNase I diminishes endothelial dysfunction and inflammation in a rat model of cardiopulmonary bypass","volume":"9","author":"Weber","year":"2019","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.neuropharm.2024.110217_bib360","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1007\/s11302-013-9369-0","article-title":"High dose of extracellular ATP switched autophagy to apoptosis in anchorage-dependent and anchorage-independent hepatoma cells","volume":"9","author":"Wei","year":"2013","journal-title":"Purinergic Signal."},{"issue":"4","key":"10.1016\/j.neuropharm.2024.110217_bib361","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.mehy.2013.06.026","article-title":"Mitochondrial-derived N-formyl peptides: novel links between trauma, vascular collapse and sepsis","volume":"81","author":"Wenceslau","year":"2013","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.neuropharm.2024.110217_bib362","first-page":"1","article-title":"Immunoassay techniques","volume":"324","author":"Wheeler","year":"2006","journal-title":"Methods Mol. Biol."},{"issue":"4","key":"10.1016\/j.neuropharm.2024.110217_bib363","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.cell.2022.12.032","article-title":"Hallmarks of neurodegenerative diseases","volume":"186","author":"Wilson","year":"2023","journal-title":"Cell"},{"issue":"6121","key":"10.1016\/j.neuropharm.2024.110217_bib364","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1126\/science.1229963","article-title":"Cyclic GMP-AMP is an endogenous second messenger in innate immune signaling by cytosolic DNA","volume":"339","author":"Wu","year":"2013","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.neuropharm.2024.110217_bib365","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s40035-021-00270-1","article-title":"The role of pathological tau in synaptic dysfunction in Alzheimer's diseases","volume":"10","author":"Wu","year":"2021","journal-title":"Transl. Neurodegener."},{"issue":"9","key":"10.1016\/j.neuropharm.2024.110217_bib366","article-title":"Toll-like receptor 4: a promising therapeutic target for Alzheimer's disease toll-like receptors in Alzheimer's disease: a therapeutic perspective","volume":"2022","author":"Wu","year":"2022","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.neuropharm.2024.110217_bib367","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/1015791","article-title":"Targeting nrf2-mediated oxidative stress response in traumatic brain injury: therapeutic perspectives of phytochemicals","volume":"2022","author":"Wu","year":"2022","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"14","key":"10.1016\/j.neuropharm.2024.110217_bib368","doi-asserted-by":"crossref","first-page":"3800","DOI":"10.1111\/j.1742-4658.2009.07094.x","article-title":"Overexpression of Tfam protects mitochondria against beta-amyloid-induced oxidative damage in SH-SY5Y cells","volume":"276","author":"Xu","year":"2009","journal-title":"FEBS J."},{"issue":"8","key":"10.1016\/j.neuropharm.2024.110217_bib369","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/s41419-020-02824-z","article-title":"TLR4 promotes microglial pyroptosis via lncRNA-F630028O10Rik by activating PI3K\/AKT pathway after spinal cord injury","volume":"11","author":"Xu","year":"2020","journal-title":"Cell Death Dis."},{"issue":"3","key":"10.1016\/j.neuropharm.2024.110217_bib370","doi-asserted-by":"crossref","DOI":"10.1128\/mbio.03632-21","article-title":"Salmonella induces the cGAS-STING-dependent type I interferon response in murine macrophages by triggering mtDNA release","volume":"13","author":"Xu","year":"2022","journal-title":"mBio"},{"issue":"5633","key":"10.1016\/j.neuropharm.2024.110217_bib371","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1126\/science.1087262","article-title":"Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway","volume":"301","author":"Yamamoto","year":"2003","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.neuropharm.2024.110217_bib372","doi-asserted-by":"crossref","first-page":"145","DOI":"10.2183\/pjab.97.009","article-title":"TNF receptor-associated factor 6 (TRAF6) plays crucial roles in multiple biological systems through polyubiquitination-mediated NF-\u03baB activation","volume":"97","author":"Yamamoto","year":"2021","journal-title":"Proc. Jpn. Acad. Ser. B Phys. Biol. Sci."},{"issue":"6593","key":"10.1016\/j.neuropharm.2024.110217_bib373","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/382685a0","article-title":"RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease","volume":"382","author":"Yan","year":"1996","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.neuropharm.2024.110217_bib374","doi-asserted-by":"crossref","first-page":"240","DOI":"10.2741\/s265","article-title":"RAGE is a key cellular target for Abeta-induced perturbation in Alzheimer's disease","volume":"4","author":"Yan","year":"2012","journal-title":"Front. Biosci."},{"issue":"1\u20132","key":"10.1016\/j.neuropharm.2024.110217_bib375","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.cell.2014.11.047","article-title":"Dopamine controls systemic inflammation through inhibition of NLRP3 inflammasome","volume":"160","author":"Yan","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.neuropharm.2024.110217_bib376","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.106263","article-title":"CSB6B prevents \u03b2-amyloid-associated neuroinflammation and cognitive impairments via inhibiting NF-\u03baB and NLRP3 in microglia cells","volume":"81","author":"Yan","year":"2020","journal-title":"Int. Immunopharm."},{"key":"10.1016\/j.neuropharm.2024.110217_bib377","article-title":"cGAS-STING signaling pathway in intestinal homeostasis and diseases","volume":"14","author":"Yang","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.neuropharm.2024.110217_bib378","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1164187","article-title":"The role of mtDAMPs in the trauma-induced systemic inflammatory response syndrome","volume":"14","author":"Ye","year":"2023","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.neuropharm.2024.110217_bib379","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.neuron.2016.06.015","article-title":"TREM2 binds to apolipoproteins, including APOE and CLU\/APOJ, and thereby facilitates uptake of amyloid-beta by microglia","volume":"91","author":"Yeh","year":"2016","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2024.110217_bib380","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1471-2377-6-12","article-title":"COX-2, CB2 and P2X7-immunoreactivities are increased in activated microglial cells\/macrophages of multiple sclerosis and amyotrophic lateral sclerosis spinal cord","volume":"6","author":"Yiangou","year":"2006","journal-title":"BMC Neurol."},{"issue":"3","key":"10.1016\/j.neuropharm.2024.110217_bib381","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1007\/s12035-017-0467-9","article-title":"NLRP3 inflammasome inhibitor ameliorates amyloid pathology in a mouse model of Alzheimer's disease","volume":"55","author":"Yin","year":"2018","journal-title":"Mol. Neurobiol."},{"issue":"3","key":"10.1016\/j.neuropharm.2024.110217_bib382","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.cell.2020.09.020","article-title":"TDP-43 triggers mitochondrial DNA release via mPTP to activate cGAS\/STING in ALS","volume":"183","author":"Yu","year":"2020","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.neuropharm.2024.110217_bib383","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s11302-015-9464-5","article-title":"Pathological concentrations of homocysteine increases IL-1\u03b2 production in macrophages in a P2X7, NF-\u0138B, and erk-dependent manner","volume":"11","author":"Zanin","year":"2015","journal-title":"Purinergic Signal."},{"issue":"3","key":"10.1016\/j.neuropharm.2024.110217_bib384","doi-asserted-by":"crossref","first-page":"939","DOI":"10.3233\/JAD-210268","article-title":"NLRP3 inflammasome: a starring role in amyloid-\u03b2- and tau-driven pathological events in Alzheimer's disease","volume":"83","author":"Van Zeller","year":"2021","journal-title":"J Alzheimers Dis"},{"issue":"4","key":"10.1016\/j.neuropharm.2024.110217_bib385","doi-asserted-by":"crossref","first-page":"817","DOI":"10.3892\/ijmm.2014.1650","article-title":"Mitochondrial DNA induces inflammation and increases TLR9\/NF-\u03baB expression in lung tissue","volume":"33","author":"Zhang","year":"2014","journal-title":"Int. J. Mol. Med."},{"issue":"4","key":"10.1016\/j.neuropharm.2024.110217_bib386","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1002\/ijc.32207","article-title":"Highly-expressed P2X7 receptor promotes growth and metastasis of human HOS\/MNNG osteosarcoma cells via PI3K\/Akt\/GSK3\u03b2\/\u03b2-catenin and mTOR\/HIF1\u03b1\/VEGF signaling","volume":"145","author":"Zhang","year":"2019","journal-title":"Int. J. Cancer"},{"issue":"7748","key":"10.1016\/j.neuropharm.2024.110217_bib387","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1038\/s41586-019-1000-2","article-title":"Structural basis of STING binding with and phosphorylation by TBK1","volume":"567","author":"Zhang","year":"2019","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.neuropharm.2024.110217_bib388","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/s41392-023-01464-x","article-title":"TRP (transient receptor potential) ion channel family: structures, biological functions and therapeutic interventions for diseases","volume":"8","author":"Zhang","year":"2023","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.neuropharm.2024.110217_bib389","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.expneurol.2015.07.019","article-title":"TDP-43 activates microglia through NF-\u03baB and NLRP3 inflammasome","volume":"273","author":"Zhao","year":"2015","journal-title":"Exp. Neurol."},{"issue":"5","key":"10.1016\/j.neuropharm.2024.110217_bib390","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/j.neuron.2018.01.031","article-title":"TREM2 is a receptor for \u03b2-amyloid that mediates microglial function","volume":"97","author":"Zhao","year":"2018","journal-title":"Neuron"},{"issue":"4","key":"10.1016\/j.neuropharm.2024.110217_bib391","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.7150\/thno.50905","article-title":"Mitochondrial ROS promote mitochondrial dysfunction and inflammation in ischemic acute kidney injury by disrupting TFAM-mediated mtDNA maintenance","volume":"11","author":"Zhao","year":"2021","journal-title":"Theranostics"},{"issue":"8","key":"10.1016\/j.neuropharm.2024.110217_bib392","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1038\/s41418-021-00767-2","article-title":"The DJ1-Nrf2-STING axis mediates the neuroprotective effects of Withaferin A in Parkinson's disease","volume":"28","author":"Zhao","year":"2021","journal-title":"Cell Death Differ."},{"issue":"9","key":"10.1016\/j.neuropharm.2024.110217_bib393","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0137721","article-title":"The cold-inducible RNA-binding protein (CIRP) level in peripheral blood predicts sepsis outcome","volume":"10","author":"Zhou","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2024.110217_bib394","doi-asserted-by":"crossref","first-page":"202","DOI":"10.3389\/fnagi.2018.00202","article-title":"TREM2-Dependent effects on microglia in Alzheimer's disease","volume":"10","author":"Zhou","year":"2018","journal-title":"Front. Aging Neurosci."},{"issue":"1","key":"10.1016\/j.neuropharm.2024.110217_bib395","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s12964-021-00738-7","article-title":"Mitochondrial DNA leakage induces odontoblast inflammation via the cGAS-STING pathway","volume":"19","author":"Zhou","year":"2021","journal-title":"Cell Commun. Signal."},{"key":"10.1016\/j.neuropharm.2024.110217_bib396","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2022.101702","article-title":"The mitochondrial unfolded protein response: a multitasking giant in the fight against human diseases","volume":"81","author":"Zhou","year":"2022","journal-title":"Ageing Res. Rev."},{"issue":"8","key":"10.1016\/j.neuropharm.2024.110217_bib397","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.1172\/JCI37607","article-title":"The TLR9-MyD88 pathway is critical for adaptive immune responses to adeno-associated virus gene therapy vectors in mice","volume":"119","author":"Zhu","year":"2009","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.neuropharm.2024.110217_bib398","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2019.105836","article-title":"TRPM2 channel regulates cytokines production in astrocytes and aggravates brain disorder during lipopolysaccharide-induced endotoxin sepsis","volume":"75","author":"Zhu","year":"2019","journal-title":"Int. Immunopharm."},{"key":"10.1016\/j.neuropharm.2024.110217_bib399","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2021.113828","article-title":"Inhibition of TLR4 prevents hippocampal hypoxic-ischemic injury by regulating ferroptosis in neonatal rats","volume":"345","author":"Zhu","year":"2021","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neuropharm.2024.110217_bib400","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1146\/annurev-pathmechdis-012419-032847","article-title":"DAMPs, PAMPs, and LAMPs in immunity and sterile inflammation","volume":"15","author":"Zindel","year":"2020","journal-title":"Annu. Rev. Pathol."},{"issue":"12","key":"10.1016\/j.neuropharm.2024.110217_bib401","doi-asserted-by":"crossref","first-page":"a016287","DOI":"10.1101\/cshperspect.a016287","article-title":"Inflammasomes","volume":"6","author":"De Zoete","year":"2014","journal-title":"Cold Spring Harbor Perspect. Biol."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390824003861?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390824003861?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,8]],"date-time":"2024-12-08T21:01:41Z","timestamp":1733691701000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390824003861"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":401,"alternative-id":["S0028390824003861"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2024.110217","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mitochondrial DAMPs: Key mediators in neuroinflammation and neurodegenerative disease pathogenesis","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2024.110217","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110217"}}